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ABSTRACT 
Gaucher’s Disease (GD) is a rare recessive disorder produced by the dysfunction of the 
lysosomal enzyme Glucocerebrosidase (GCase). GCase catalyses the cleavage of the 
glycolipid Glucosylceramide. The lack of functional GCase leads to the accumulation 
of its lipid substrate in lysosomes causing GD. GD presents a great phenotypic 
variation, symptoms ranging from asymptomatic adults to early childhood death due to 
neurological damage. More than 250 mutations in the protein GCase have been 
discovered that result in GD. Being able to link structural modifications of each 
mutation to the phenotypic variation of GD would enhance the understanding of the 
disease. The aim of this work is to understand the structural dynamics of wild type and 
mutant GCase.   
A model of the complex of the enzyme GCase with its facilitator protein, Saposin-C 
(Sap-C) was generated using Protein-Protein docking (PPD). In this work, a 
knowledge-based docking protocol that considers experimental data of protein- protein 
binding has been carried out. Here, a reliable model of the enzyme GCase with its 
facilitator protein is presented and is consistent with the experimental data.  
To understand the structural mechanism of function of the enzyme GCase, it was 
imperative to study its structural dynamics and conformational changes influenced by 
its interaction with other components including lipid bilayer, facilitator protein or 
substrate. Coarse-Grained MD (CG-MD) was employed to study lipid self-assembly 
and membrane insertion of the complex. Classical Atomistic MD (AT-MD) was used 
to study the dynamics of the interactions between different components of the 
simulation. 
Furthermore, the results of ten different AT-MD simulations  sampling 9 𝜇s have been 
analysed. An activation method of GCase by Sap-C has been proposed, the change in 
conformation of GCase when its facilitator protein is present has been highlighted, 
through the stabilization of the loops at the entrance of the binding site. The differences 
in protein-protein binding when GCase is mutated have also been emphasised.  
Finally, Anharmonic Conformational Analysis and Markov State Models have been 
used to build a kinetic model of the system. This model supports our activation 
mechanism hyphothesis.  
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IMPACT STATEMENT 
 
In this thesis, I present our enhanced understanding of the structural mechanism of 
function of the enzyme Glucocerebrosidase and its role Gaucher’s Disease. Gaucher’s 
Disease (GD) is a rare recessive disorder, whose clinic manifestations ranges from 
death at early age due to neurological damage to asymptomatic adults, and is 
concomitant with other diseases such as Parkinson’s Disease or Lewy Body Dementia. 
More than 250 mutations in the enzyme Glucocerebrosidase have been reported so far, 
that result in GD. However, no one has yet been able to link the clinical complexity of 
the disease to the structural implications of the mutations. Understanding the 
differences between the structural mechanism of action at atomistic level between the 
wild type and the mutants, would help us provide the crucial link between genotype 
and phenotype. 
Secondly, I used a combination of data reduction methods including Anharmonic 
Conformational Analysis in conjunction with Markov State Modelling to construct a 
kinetic model and propose a potential mechanism of activation of Glucocerebrosidase 
in complex with its facilitator protein Sap-C. Structural dynamics of such a complex in 
a membrane environment has never been reported before.  
Finally, the interactions at the protein-protein interface can potentially be exploited to 
manipulate the activation mechanism. This can have important ramification in the 
design of peptides that activate Glucoserebrosidase.  
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CHAPTER 1: INTRODUCTION	
1.1. General Introduction  
Gaucher’s Disease (GD) is a metabolism disorder with a variety of clinic manifestations 
that ranges from asymptomatic adults to early age death due to acute neurological 
damage.1,2 It is a recessive disease caused by mutations in the gene that encodes the 
Glucocerebrosidase enzyme (GCase). Mutations yield a dysfunctional enzyme. GCase 
is a lysosomal hydrolase that cleaves glycolipids. Its malfunction causes glycolipid 
accumulation in lysosomes, which is responsible for the symptoms of GD.
 
At least 250 
mutations in GCase have been reported.3 So far, there is no structural information that 
relates mutations in the enzyme with the different phenotypes of the disorder,4 though 
few experimental techniques do permit the study of structure and function of individual 
amino acids mutations.5 
In this study, we present a structural understanding of the molecular mechanism of 
function of Glucocererbrosidase in complex with its facilitator protein Saposin-C, 
including two commonly occurring disease phenotypes, using structural bioinformatics 
tools.  
1.2. Introduction to membrane lipids degradation in Lysosomes and Lysosomal 
storage disorders.  
Lysosomes are the major degradation organelles in eukaryotic cells. They are relatively 
small acidic compartments of spherical form containing a number of different enzymes 
necessary for degradation of biomolecules. Usually referred as stomach of the cell, 
these organelles represent a key point in cell homeostasis.6,7
 
Components of eukaryotic 
membrane are broken down into their building blocks by lysosomal hydrolases and sent 
to the cytosol to be re-utilised, this being the principal mechanism of cell membrane 
turnover.6-8 
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Figure 1.1: Schematic illustration of the membrane component turnover. Membrane building 
blocks are endocytosed, carried to the lysosomal and degraded in the lysosomal lumen. Taken 
from reference 7.  
 
Glucosphingolipids (GSL) are ubiquitous components of eukaryotic cell membranes. 
They are complex glycolipids formed by a ceramide moiety and an oligosaccharide 
chain. These membrane components are degraded within the surface of intra-lysosomal 
membranes. The sequential action of different membrane hydrolases cleaves these 
components on their glycosidic bonds.9
 
When the oligosaccharide chain of the 
glycolipids has less than four sugars, hydrolytic enzymes dissolved in the lysosol have 
difficulties to reach their substrate embedded in the membrane. In addition, they require 
the mediation of small protein cofactors that solubilise these complex lipids, thus 
making them accessible. These facilitator proteins are called Sphingolipid Activator 
Proteins (SAP).7-10
  
Mutations in genes encoding lysosomal hydrolases are responsible of a group of genetic 
disorders known as Lysosomal Storage Disorder (LSD).10
 
As a consequence, 
undegraded macromolecules are accumulated in the lysosome causing severe clinical 
symptoms. Furthermore, accumulation of complex lipids such as GSL usually entails 
accumulation of other hydrophobic products via co- precipitation.6,9,10
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This thesis focuses on the study of Gaucher ́s Disease, a rare LSD produced by the 
deficiency or malfunction of the lysosomal hydrolase Glucocerebrosidase.  
1.3. Gaucher ́s Disease: classification, pathophysiology and epidemiology.  
Gaucher ́s Disease (GD) is the most spread LSD known. It was first described by 
Philippe Gaucher, a medical student, in 1882. GD is a rare autosomal recessive disorder 
produced by mutations in the gene for the lysosomal enzyme acid-β-glucosidase or 
glucocerebrosidase (used hereafter). Mutations result in reduced hydrolytic activity, 
poor intracellular stability or diminished trafficking of the enzyme, causing 
accumulation of its principal substrate: glucosylceramide in the lysosomes.1,3
 
The gene 
is located on chromosome 1 and it is composed of 11 exons, where single nucleotide 
substitutions, deletions, insertions and recombination with a highly homologous 
pseudo-gene (ps- GBA) located 16 kb downstream are observed.3 Up to 250 mutations 
of this gene account for the wide range of symptoms seen in Gaucher ́s disease.3,11
  
From lethality in early childhood to asymptomatic adults, GD shows a great variety in 
its symptomatology, including neurological involvement that ranges from eye 
movement disorder to severe neurologic degeneration. The disease has been classified 
into three types: non-neuropathic, acute and chronic.10 
Type 1 GD or non-neuropathic (GD1): It is the most common form of GD and is 
normally diagnosed in late childhood, or early adulthood although some patients remain 
asymptomatic throughout their entire life. It is characterised by hepatosplenomegalia, 
thrombocytopenia which causes spontaneous bleeding in some cases, anaemia, pain 
crisis, bone involvement, including pathological fractures, osteoporosis or deformities, 
skin involvement, and in rare cases lung involvement, such dyspnoea, or pulmonary 
hypertension, and heart involvement. 1,2,11
 
Type 2 GD or acute neuropathic (GD2): This form is characterised by a progressive 
neurological degeneration causing individuals to die by age 2 years. The symptoms 
include limb rigidity, spasticity or eye movement failure. Patients with this type of GD 
typically present strong skin involvement due to modification in the ratio 
glucosylceramide/ceramide in the stratum corneum. GD2 may also result in hydrops 
fetalis in some cases. 1,2,11 
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Type 3 GD or chronic neuropathic (GD3): The course of this type is more similar to 
that of GD1 with mild neurological involvement that range from eye movement defects 
such as saccade initiation failure or strabismus to learning disabilities, developmental 
delays, autism disorder and in some cases dementia, convulsions or ataxia.
 
.1,2,11 
Although GD is a pan- ethnic disease it has been extensively reported to have a greater 
incidence in Ashkenazi Jews, with roughly 1 case in 800 live-births for this population 
against the approximately 1:50000 in general population. Among the different forms of 
GD, type 1 is by far the most common with roughly 1:40000 cases, whereas the other 
two forms occur in 1 individual in every 100000. 1,2  
The pathophysiology of GD still remains unclear. Although glucocerebrosidase and its 
main substrates glucosylceramide (GluCer) and glucosylsphingosine are present in 
every cell, the complex lipids are especially abundant in red and white cell membranes. 
Thus, macrophages would be the most affected cells, incapable of metabolising the 
complex glycolipid after the blood cells turnover.1,11
 
Consequently, macrophages, 
fattened with GluCer, would be accountable for the extensive organomegalia. As 
osteoclasts also belong to the mononuclear phagocyte lineage, could also be affected 
producing the skeletal disease. Therefore macrophage has become the centre of study 
to understand the mechanism of GD and to develop a treatment. However, this seems 
to be unsatisfactory to explain the complex symptomatology.12 More recently, 
deregulation of other immune cells, apart from the macrophage, has been reported in 
clinical studies.13
 
Furthermore, it has been demonstrated that the bone involvement 
could be more related to an inhibitory action by complex glycosphingolipids of 
osteoblastogenesis. Finally, extramedullary haematopoiesis was identified that may be 
producing the organomegalia. These latest studies have given new perspectives over 
the study of this complex disease.12,13 
Apart from the complex symptomatology and the phenotypical variation, some studies 
have shown how GD may predispose to the development of other disorders, or at least 
that there is certain concomitance with other diseases that deserve to be highlighted.3
 
A well-studied association has been between GD and Parkinson Disease (PD).2
 
Mutations in GCase have been found in samples taken from PD patients in higher 
proportion than in the  control group.14 On the other hand, some cases of GD have been 
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reported to show Parkinsonian manifestation in adulthood.15
 
Another proposed 
association has been between GD and Dementia with Lewy Bodies (DLB), similar to 
that observed with PD. Some cases with confirmed DLB have been found to carry 
mutations in GCase; moreover GD cases have been reported to develop Lewy bodies.16
 
Finally, GD has also been associated with some types of malignancies including 
multiple myeloma and haematological cancers.1,2,11
  
Few strategies have been tested for the treatment of GD. Administration of exogenous 
enzyme or enzyme replacement therapy (ERT), easily recognisable by macrophages is 
still the treatment of choice in most of the cases. This strategy has shown to be effective 
reducing organomegalia, anemia and cytopenia. However, it has the disadvantage of 
not passing the blood-brain barrier, being unable to ameliorate bone and lung disease, 
as well as its price and its administration route: parenteral.1
 
Substrate reduction by 
partial inhibition of glucosylceramide synthase, first enzyme in the route of the 
biosynthesis of glucosphingolipids has been another strategy for the treatment of 
GD.17,18
 
This is the case of N-butyl-deoxynojirimycin (miglustat), which was the first 
of these agents to be approved by the Food and Drug Administration (FDA) as valid 
treatment for patients who presented any contraindication to ERT.19
 
Oral 
pharmacological chaperones, or agents that ease protein folding, and gene therapy are 
being the latest areas to be explored for the treatment of this disease.1,11,13 
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1.4. Glucocerebrosidase: function and structure.  
Glucocerebrosidase also called acid-β-glucosidase (GCase), is a lysosomal enzyme 
composed of 497 amino acids. GCase is synthesised in the rough endoplasmic 
reticulum (ER) as a pre-enzyme with 19 amino acids leader polypeptide in its N-
terminus.4
 
The pre-enzyme loses this sequence as part of the complex post-translational 
events that occur prior to its traffic to the lysosome.4,20,21 Unlike other lysosomal 
hydrolases, GCase is not marked with mannose-6-phosphate (M-6-P) for its traffic to 
the lysosome, but its association with Lysosomal Integral Membrane Protein (LIMP-2) 
assists in its entrance in the organelle.20,21  
GCase is a hydrolytic enzyme that cleaves its main substrate Glucosylceramide 
(GluCer), into glucose and ceramide. Although GluCer is its main substrate, the enzyme 
also breaks down the des-acyled form of this glycolipid - glucosylsphingosine.4
 
The 
lipidic tails of both glycolipids are embedded in the intra-lysosomal membrane such 
that both substrates lay inaccessible. This makes GCase need the assistance of a second 
facilitator protein Saposin-C (Sap-C) to anchor to the membrane. Sap-C belongs to the 
Sphingolipid Activator Proteins. Unlike other members, it does not only mediate the 
contact of the GCase with its natural ligands, but it is also known to be able to stimulate 
the enzyme activity directly.22,23
 
Recent investigations have revealed that both GCase 
and Sap-C associate in the membrane.4,7,23 
GCase is a globular protein. As it is shown in Figure 1.3, this enzyme is composed of 
three different domains: Domain I (residues 1-27 and 383-414) is a small three stranded 
anti-parallel β-sheet, Domain II (residues 30-75 and 431-497) is an independent 8 
stranded β-barrel resembling an immunoglobulin domain and Domain III (residues 76-
381 and 416-430) is a (𝛼/𝛽)8 TriosePhosphate Isomerase (TIM) Barrel, containing the 
active site. Domains I and III interact tightly and are linked by one of the loops at the 
entrance of the binding site. Domains II and III are separated by a long loop that acts 
as a hinge. Structural folds similar to Domains II and III can be found in other 
hydrolases such as α- galactosidase. 4,25  
In GCase, residues E340 and E235 have been identified as the catalytic residues within 
the active site.24 Residue E340 is the catalytic nucleophile and E235 the acid-base 
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residue. In the first step, E235 would supply a proton to the ceramide group.4,24,25 As 
illustrated in Figure 1.2, a nucleophilic attack is initiated by the oxygen atom of the 
residue E340 on the anomeric carbon. An intermediate adduct is formed, following by 
its hydrolysis.  
 
 
Figure 1.2: Catalytic mechanism of the enzyme GCase. The nucleophilic attack by E340 results 
in the formation of an adduct and release of the ceramide group (OH-R). Acid base residue 
E235 supplies a proton to the ceramide group. The adduct is hydrolysed and a molecule of 
glucose is realised. 
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Figure 1.3: Structural arrangement of Glucocerebrosidase. The enzyme consists of 3 different 
domains: Domain I is a three-stranded anti-parallel β-sheet (green), Domain II is an 8 stranded 
β- barrel (pink) and Domain III is the TIM barrel (yellow to blue). The numbers indicate the 
name of helices in the TIM barrel. 
The active site lies in a cavity formed at the centre of the TIM barrel motif. Residues 
R120, D127, F128, W179, N234, Y244, F246, Y313, C342, S345, W381, N396, F397 
and V398, constitute the glucose-moiety binding region, and residues E235 and E340 
are the catalytic residues (Fig. 1.4).4,24,25
 
Some of these aromatic residues may play an 
important role in molecular recognition of the substrate.26
 
Other residues, inside the 
pocket, create a hydrogen-bonding network that holds the substrate in the correct 
position for hydrolysis. Some of these residues do not change their conformation upon 
GluCer binding, whereas others are flexible. Particularly, Y313, N396 and F397 show 
high thermal B-factors in crystal structures.27
 
It is not clear what parts of the active site 
are implied in holding the ceramide tails. It is assumed that they are embedded in the 
membrane during the catalysis.4,24
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Five loops (Loop-1 (residues 311-319), Loop-2 (residues 345-349), Loop-3 (residues 
394-399), Loop-4 (residues 237-248) and Loop-5 (residues 283-288)) at the entrance 
of the active site are believed to rearrange in different conformations allowing and 
blocking the entrance and holding the substrate in the active site (Fig. 1.5)4.
 
Different 
conformation of these loops has been reported in the different available crystal 
structures of the GCase. Especially important are the changes in Loop 1, Loop2 and 
Loop 3, that determine the accessibility to the binding site.4,24,27   
 
 
Figure 1.4: Residues in the binding site. Five loops at the entrance of the binding site have 
been labelled: Loop-1 in yellow, Loop-2 in purple, Loop-3 in green, Loop-4 in orange and 
Loop-5 in red. Catalytic residues (E235 and E340) have been coloured in cyan,  represented 
as spheres and labelled in red. The rest of residues of the binding site are in dark blue. 
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Figure 1.5: Conformational changes in the active site loops. Rearrangement of loops at the 
entrance of the active site in (a and b) inactivated GCase (PDB id 1OGS), where the L1 is in 
extended conformation and (c and d) activated GCase (PDB id 2NSX), where L1 adopts helical 
conformation. Individual loops have been labeled L1-L5. 
Two different configurations of the Loop-1 (residues 311-319) have been reported: 
extended and helical, are shown in Figure 1.6. Residue D315 in the middle of the loop 
leans towards loop 2 in the extended conformation, establishing hydrogen bond with 
G244. Yet, in the helical conformation the residue seems to tend towards residue N370, 
to form a water-mediated hydrogen bond with the N370 and a salt-bridge with R285. 
Residue Y313 changes from establishing hydrogen-bonded interaction with E235 to 
E340 when the loop conformation shifts from extended to helical conformation.4 
Residue W312 also changes hydrogen bonding partner with a change in conformation 
from R285 in extended to C342 in the helical conformation.
 
Activator ligand 
Isofagomine (IFG) has been reported to be better held inside the pocket when Loop-1 
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is in helical conformation.27
 
Crystal structure of mutant N370S shows extended 
conformation.28
 
Molecular docking studies demonstrated that extended Loop-1 clashes 
with the binding site. Moreover, GlcCer could not be properly positioned within the 
binding site when the Loop-1 is in the extended conformation.4,27  
 
Figure 1.6: Conformations of Loop-1 (yellow) are illustrated in (a) extended and (b) 
helical conformations. The movements in the side chains of the residues W312, Y313 
and D315 are prominent. Loop-1 is in helical conformation when GCase is bound to 
an activator ligand in the active site. 
Three residues, (R395, N396, F397) from Loop-3 play important roles in the 
availability of the active site. In the apo structures when Loop-1 in extended 
conformation (where active site is not available) R395 is pointing towards Y313 and 
makes hydrogen bonds with the catalytic residues (E235 and E340). The side chain of 
F397 is oriented towards the centre, while the side chain of N396 is directed away from 
the active site. The orientation of F397 side chain and hydrogen bond network of R395 
blocks the entrance of the active site. In the helical conformation of Loop-1, the side 
chains of R395 and F397 point out of the active site, while the side chain of N396 points 
inwards (Fig. 1.7). This creates a cavity that can accommodate the substrate.4,27
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Figure 1.7: Different conformations of the residues (a) R395, (b) N396 and (c) F397 in Loop-
3 at the entrance of the active site. Activated GCase (pdb code: 2NSX) has been coloured in 
blue, whereas Apo-GCase (pdb code: 1OGS) has been coloured in yellow. Please note that 
R395 and F397 are pointed towards inside of the binding pocket when in inactivated 
conformation, thus impeding the entrance of the ligand in the active site. N396 is pointing 
towards inside of the active site when in activated conformation, probably having a role holding 
the ligand through electrostatic interactions in the active site. 
As the lysosomal enzyme requires sulphate or phosphate ions in the crystallization 
media, it has been proposed that some of the ions that remain in the crystal structure 
may coincide with some of the sites of lipid membrane binding. Two sites in particular 
have been identified as possible places of association to the membrane, one among the 
residues S12, R44, R353, S356, R357 and D358, and another formed by the residues 
K79, W228, R277 and H306. 29 
It has been reported that although glycosidation did not affect to the catalytic activity 
or activation via Sap-C, it was nevertheless essential for the formation of the active 
enzyme. Five glycosidation sites have been identified at Asparagines N19, N59, N146, 
N270 and N462.30 
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1.4.1. Mutations in Glucocerebrosidase  
Although approximately 250 mutations of the enzyme have been reported so far, only 
one, N370S, is responsible for more than the 70 per cent of the cases of GD type 1.31,32 
The mutations D409H and D409V are important mutations in GD type 3,33 L444P have 
been associated with neurological symptoms34,35
 
and E326K does not produce GD but 
has been extensively reported to be found in patients with PD16,36-37.  
 
Figure 1.8: GCase residues that cause Gaucher’s Disease when mutated. Reported GCase 
residues mutated in Gaucher’s disease have been represented as spheres, Loop-1 and Loop-2 
at the entrance of the binding site have been coloured in yellow and purple respectively. 
Residues N370 (70 % of the cases of GD1), L444 (Neurological symptoms), D409 (GD3) and 
E326 (PD) have been labelled in red. 
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1.5. Saposin-C: Function and structure  
Saposin-C (Sap-C) is a small intra-lysosomal membrane protein. It is composed of 78 
amino acids and it is about 10 kDa. It belongs to the Sphingolipid Activator Proteins 
(SAPs), which are non-enzymatic membrane proteins that mediate the association of 
proteins with their lipid substrate in the intra-lysosomal membrane.7 Sap-C derives 
from the proteolytic cleavage of prosaposin in four highly homologous proteins Sap A-
D. Despite their resemblance and high homology all four proteins are specific for 
different lysosomal hydrolases, and its absence or malfunction produces different LSD. 
7,38 
The structure of Sap-C consists of four amphipathic α-helices forming a compact 
hydrophobic core and hydrophilic side chains on the surface (Fig. 1.9). Three di-
sulphide bridges tightly bind the helices together. Apart from this, another 
conformation of the protein has been detected under detergent conditions. An open 
conformation of the saposin, in which the hydrophobic core is left exposed, has been 
identified under solvation with SDS. Sap-C has been crystalized as a monomer, but 
under low pH and detergent conditions, it has been reported to self-associate in dimers 
and trimers. Some studies have suggested that these associations may be relevant for 
the mechanism of action of these proteins.37 
 
Figure 1.9: Conformations of Sap-C. (a) closed and (b) open conformation. Numbers indicate 
the name of the helices. Disulphide bridges have been illustrated as sticks. 
The mechanism by which Sap-C destabilizes intra-lysosomal vesicles to make GluCer 
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accessible to its hydrolytic enzyme is not well known. The binding to the membrane is 
known to occur in a reversible pH dependent manner. After the negative charge on the 
surface of Sap-C is neutralized owing to an acidic pH, the protein is ready to bind to 
the phospholipids of membrane to carry out its action. It is known that Sap-C not only 
mediates the interaction of GCase with its natural substrate but also directly induces a 
conformational change in the hydrolase that allows it to complete its catalytic action.22
 
It has also been demonstrated that Sap-C may protect GCase against the proteolytic 
action of lysosomal proteases.39
  
As a consequence, mutations in the GCase that affect the association to Sap-C would 
result in not only diminished activity, but also in more vulnerability of the enzyme to 
its early digestion in the lysosome, which would produce Gaucher’s Disease. 
Furthermore, the mutations in the gene of prosaposin, that lead to the malfunction or 
absence of Sap-C in the lysosomal compartment were reported to be cause of a juvenile 
form of Gaucher’s disease. 40,41 
1.6. Interaction of Glucocerebrosidase with Sap-C.  
The area of interaction of GCase and Sap-C has not been accurately established. 
Experimental studies demonstrated that the GCase mutant N370S had decreased 
capacity of binding to Sap-C and to the phospholipid membrane. Since then, it has been 
postulated that the binding site of Sap-C in GCase should lie in the vicinity of N370.42
  
On the other hand, other experimental studies have focused on finding what domains 
of Sap-C that interact with GCase.43,44 A study, carried out through competition assays 
of synthetic lipids, revealed two domains capable of binding and activating GCase. 
They included Domain 1: residues 6-34, binding site: 6-27 and activation site: 27-34 
and Domain 2: residues 41-60, binding site: 45-60 and activation site: 41-49. Domain 
2 in that case was reported to bind GCase by at least one order of magnitude more 
strongly.45
 
Another study, conducted with chimeric saposins, determined the activator 
region of Sap-C to be located between residues 47-62.43 
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1.7. Molecular modelling and structural bioinformatics techniques 
Molecular modelling comprises of all those computational or theoretical methods that 
can be used to model or emulate the behaviour of biomolecular systems in silico. These 
methods include techniques to predict the binding mode of two interacting 
biomolecules (molecular docking), methods to predict the evolution in time of a 
biomolecular system, such as molecular dynamics simulations (MD) or methods to 
model the kinetics of the systems. Thereby, molecular modelling provides a valuable 
strategy to understand a biological system at a detail, which is impossible to obtain by 
other experimental techniques. Computational and theoretical methods are especially 
suitable for the study of the implications of different mutations in a protein, when 
structural details need to be known. The computational techniques used to carry out this 
research are going to be introduced in detail in successive chapters. 
1.8. Previous Studies  
A computational docking model for the interaction of GCase with Sap-C was proposed 
by Atrian et al. in 2008.46
 
The model relies on both structural and evolutionary 
information of the pair of proteins. Through the study of correlated mutations in seven 
pairs of homologous proteins of different species, they identified residues, which are 
important for the protein-protein interaction. This information was then used to limit 
the search of docking poses. This investigation proposed that the binding site of Sap-C 
with GCase is located between the helices 6 and 7 of Domain III and Domain II, and 
include the residues: L314, L317, A318, W348, D358, Q362, H365, S366, T369, N370, 
L372, Y373, K441, D443-D445, R463, S464 and Y487. The interacting residues of 
Sap-C proposed to form part of the interaction were: E9, D20, E25, S56, S57, L59, S60, 
L62- S67, E69, L70 and M74. The protein-protein docking was carried out between an 
inactive structure of GCase and an open and closed conformation structure of Sap-C.
  
While the proposed model is a good starting point to understand GCase and Sap-C 
protein-protein interactions, it has two fold limitations. Firstly, it is unable to account 
for experimental data, as the residues they proposed to form part of the binding site do 
not coincide with the experimental studies mentioned44,43. Secondly, there is no 
structural information regarding the anchoring of the complex with the membrane.  
CHAPTER 1: INTRODUCTION 
	
 38 
Few attempts have been made to explain the different effects of mutants via Molecular 
Dynamics simulations. In 2007, Zubrzycki et al. aimed to understand the behaviour of 
two mutants, namely: L444P and L444R.47
 
They carried out 1 ns molecular dynamics 
in explicit solvent. They also performed blind ligand docking to identify the most 
metabolically important residues. The ligands used for the docking experiments were: 
substrate (GluCer), an inhibitor (conduritol-β- epoxide) and the product (glucose). The 
conclusions drawn from this study were, although L444P and L444R result in the same 
phenotype of Gaucher ́s disease (type 3), they might be a result of different structural 
consequences. While L444R conceals the hydrophobic core of domain II due to steric 
occlusion, L444P was shown to lower the flexibility of loop 2 at the entrance of the 
binding site. Residues D443 and D445 were demonstrated to be somehow implicated 
in the binding of the ligands in the active site. 
In 2010, Offman et al. studied the dynamics of the N370S and other important mutants 
(F213I, D409H, L444P and R496H).48
 
A 10 ns molecular dynamics simulation study 
was intended to provide an explanation to the reduced activity of the mutants. An active 
form of the enzyme was used as a starting structure. In the N370S simulation, a change 
in hydrogen bonding pattern in the active site was observed when it was compared to 
the wild type simulation. A change in contact pattern made the binding site smaller and 
less accessible for the ligand. In addition, a change in the conformation of the loop 1 in 
the vicinity of the binding site was also reported. The study also found that the said 
changes were reverted upon the binding of a pharmacological chaperone in the mutated 
enzyme.
  
The studies reported by Zubrzycki et al. and Offman et al. explained structural 
interactions in selected mutants. However, they lacked information on the interactions 
with Sap-C, membrane anchoring and the influence of membrane lipids/substrate on 
the structure of GCase/Sap-C complex. Finally, the time scales of the molecular 
dynamics simulations were too short to produce meaningful results. 
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1.9. Aims and objective of this thesis 
In order to improve our understanding of the structural role of GCase in Gauchers 
disease, this thesis aims to: 
1. Construct a knowledge-based protein-protein model of GCase-Sap-C complex 
2. Identify how the complex binds to the membrane 
3. Understand dynamics of interactions at the GCase-Sap-C interface 
4. Investigate the influence of Sap-C on the activation mechanism of GCase 
5. Compare the differences between wild-type and mutant GCase in complex with 
Sap-C. 
 
1.10. Preliminary conclusions and goals achieved 
In this chapter, I have explored the biological importance of the enzyme 
Glucocerebrosidase whose lack of activity leads to the most common Lysososmal 
Storage Disorder - Gauchers Disease. Understanding the structural activation 
mechanism of this lysosomal enzyme is the cornerstone for unravelling the complex 
phenotypic profile of Gauchers disease.  
In this thesis, a combination of computational tools has been employed to elucidate the 
activation mechanism of the enzyme Glucocerebrosidase by its facilitator protein 
Saposin-C. Firstly, a knowledge-based docking protocol that considers experimental 
data of protein- protein binding has been used to generate the Glucocerebrosidase-
Saposin-C complex. Next, a multiscale molecular dynamics simulations have been 
employed to study lipid self-assembly, membrane insertion and dynamics of the 
interactions between different components of the complex. Based on a total sampling 
of 9 𝜇s, we propose a model that explains the structural activation mechanism of the 
enzyme GCase facilitated by its activator protein Saposin-C. Conformational changes 
in the loops at the entrance of the binding site are stabilized by direct interactions with 
Saposin-C. A loss of interactions with Saposin-C, result in destabilization of the 
complex and thus explaining the structural basis of pathophysiology arising in N370S 
and L444P Glucocerebrosidase mutants.
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CHAPTER 2: GLUCOCEREBROSIDASE- SAPOSIN- C: PROTEIN-PROTEIN 
MODEL.  
2.1. Introduction  
Understanding the interaction of GCase with its facilitator protein, Sap-C, was the first step 
in our research towards a comprehensive explanation of the structural mechanism of 
function and implications of the mutations causing Gaucher’s disease. The existence of 
high resolution 3D structures of individual components including GCase and Sap-C, as 
well as the advanced docking algorithms encouraged us to generate computational models 
of the GCase-Sap-C complex.  
Molecular recognition occurs due to the formation of specific attractive interactions at the 
protein-protein interface. Computationally predicting those highly specific interactions has 
been called “the docking problem”, and different algorithms to solve it have been probed 
since the eighties.49,50
 
When two interacting partners are as big as two proteins, 
determination of the binding mode becomes very challenging due to the multiple degrees 
of freedom. Consequently, such algorithms normally neglect the movement of the side-
chains and protein domains. The proteins are treated as relatively rigid bodies and limit the 
search to six degrees of freedom. On the other hand, the site of interaction in the protein 
surface is not as obvious as it is when it interacts with its substrate, making the search even 
more difficult. The availability of experimental data dramatically accelerates the search 
and increases the chance of obtaining the correct binding mode.51,52,53
 
 Solving the docking problem requires three basic components, namely: a mathematical 
model that effectively represents the system, usually based on geometrical features of the 
protein surface; an efficient search algorithm able to explore the conformational space at a 
reasonable speed and a scoring function, that scores and ranges the different conformations 
relying on energy terms and/or shape complementarily, that should ideally be able to 
distinguish the native conformations and reject the non-native ones. Moreover, in protein-
protein docking it is also necessary to implement a subsequent energy-relaxation method, 
since the proteins are treated as rigid bodies, the solutions are prone to have steric clashes.51 
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Different types of the components mentioned above and their different combination define 
the variety of docking methods currently available. In this project, we have used two 
docking programs: Hex and Haddock, the details of which are explained below.  
2.1.1. HEX  
Hex is a protein-protein docking method in which protein surfaces are depicted as skins 
constructed using Fourier expansions of spherical polar coordinates of N orders that 
represent protein surface shape, charge, density and surface electrostatic properties.55,57 
Unlike geometric search of protein shape complementarity, Fourier Correlation methods 
have the advantage of computing the level of overlap between two systems, represented as 
Cartesian grids, very rapidly and automatically penalising steric clashes between them, 
thus accelerating the search. 54 Furthermore, this method allows to perform a low-quality 
search by decreasing the number of expansion orders (polynomial powers).  Lower order 
expansions decrease the quality of the representations which facilitates a quick preliminary 
analysis of the less relevant conformations. The reduction of the expansion orders also 
provides some degree of softness in the representations which allows to incorporate certain 
protein flexibility. 51,55,56 
Protein shapes are defined as Gaussian density functions. The volume between the solvent 
accessible surface (SAS) of the proteins and the van der Waals surface of the protein atoms 
is the so-called skin. So that, the van der Waals surface of the protein would be the interior 
skin and can be calculated as the sum of the relative contribution of each atom to the density 
function and can be represented in a 3D grid. The SAS bounds the limits of the exterior 
skin which is defined by making a test sphere roll over the van der Waals surface. Interior 
and exterior skins are represented as density functions 𝜏 (ṟ) and σ	(ṟ) respectively, which 
equals to one inside the skin and zero anywhere else, as shown in equation 2.1 and 2.2.53-
55 
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σ	 ṟ = 	 1; 		𝑟	 ∈ 𝑜𝑢𝑡𝑒𝑟	𝑠𝑘𝑖𝑛0; 		Otherwise                  τ	(ṟ) = 	 1; 		𝑟	 ∈ 𝑠𝑢𝑟𝑓𝑎𝑐𝑒	𝑎𝑡𝑜𝑚0; 		Otherwise           (2.1, 2.2) 
 
Density functions can be approximated as expansions of various orders N. Increasing N 
results in an increase in shape resolution, but also in computational time. Medium orders 
are recommended to conduct a low-quality search that allows rejecting the least relevant 
conformations. In subsequent steps, higher N may be used for a softer analysis of the best 
solutions.53-55
 
The idea behind the use of the skin representation of proteins is to maximize the overlap 
between the interior skin of one protein and the exterior skin of its docking partner. The 
shape complementarity score (S) accounts for the volume of solvent displaced upon 
association and penalizes the steric clashes produced by the interior skin overlap of both 
proteins:55 𝑆 = (	σ	H 	ṟH 	τI ṟI +		τH ṟH 	σI ṟI )	𝑑𝑉 − 𝑄	 τH	τI𝑑𝑉	                (2.3) 
where the first term refers to the volume of solvent displaced and can be used as an 
approximation to the hydrophobic free energy association, and the second term accounts 
for the interior-interior skin overlap, multiplied by a penalty factor Q=11.  
The search method of the conformational space in Hex differs considerably from that in 
former Fast Fourier Transform (FFT) algorithms. The search is carried out in gradual 
rotations more than in translational searches, which simplify the transformation of 
coefficients of the spherical polar parameterization. The space search is covered in six 
degrees of freedom, five Euler angles, four rotational angles (two for each protein, β1, γ1 
and β2, γ2) and one axial (α) and one translational degree (Fig. 2.1). Each protein rotates 
around its own centroid in gradual increments of the rotational angles generated from 
icosahedral tessellations of the sphere; the distance between centroids also varies in 
translation operations. A common coordinate system for both proteins is assumed. 53,55
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Figure 2.1: Representation of the docking search using icosahedral tessellation. A and B represent 
the coordinate origin of the two proteins. Where β and γ are the molecular rotational increments 
generated by tessellations for each protein. α indicates the twist angle. 
Hex also offers different options for docking post-processing. The simplest option is to 
count steric clashes between not bonded atoms through a bump counter. The program also 
performs Molecular Mechanics (MM) refinement based on hydrogen bond (12-10) and soft 
Lennard-Jones (12-6) potentials, and it is an adaptation of Optimized Potentials for liquid 
Simulations (OPLS)58 force field.55 
The final docking score in Hex is the sum of the shape-based correlation energies, which 
is a combination of S (complementary score) and electrostatic energy, and the OPLS 
energy at the minimized orientation, as shown in equation 2.4. 53 𝐸PQPHR 𝑅, 𝛽U	, 𝛾U, 𝛼W, 𝛽W, 𝛾W = 	𝐸XYHZ[ +	𝐸QZRX                      (2.4) 
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2.1.2. Haddock  
Haddock is a data-driven docking method, in which either known biophysical information 
or theoretically predicted information about the protein-protein interface drives the docking 
process.59,60 
The program requires of a list of residues directly implicated at the interface (active 
residues) or potentially implicated on it (passive residues) to start the process. Ambiguous 
Interaction Restraints (AIRs) are applied over the selected residues. An AIR can be defined 
as an ambiguous intermolecular distance, at a maximum of 3 Å, between each active 
residue of one protein and the rest of the selected residues (active and passive) of the partner 
protein. An effective distance between pairs of atoms determines an AIR energy term 
calculated through soft- square harmonic potentials:57 
𝑑\HI]^^ = ( U_`abcdefghij`kldemUgnokIpmUghij`kqabmU )(rsf)         (2.5) 
Where 𝑁uvwqx is the number of atoms of a given residue, 𝑁y]x indicates the sum of active 
and passive residues of a protein. A sum averaging of 1/r6 is used to emulate the attractive 
term of a Lennard-Jones potential, this guarantees that the restraints are satisfied as two 
atoms of two proteins are in contact. 
The first step in the docking protocol consists of a rigid-body energy minimization.58 In 
the first four cycles the proteins are allowed to rotate, then to rotate and translate and finally 
the pair stays docked. From there, the 200 best conformations in energy terms pass to a 
second stage of three cycles of simulated annealing refinement or semi-flexible refinement. 
Finally, in the third stage, the complexes are subjected to three short molecular dynamics 
runs. In the first, all the atoms are restrained except for those on the interface, in second 
the atoms at the interface are restrained, and in the third the backbone atoms outside the 
interface are restrained.57-58 
In every stage, each docking conformation is scored and ranked based on average energy 
terms electrostatic, van der Waals and restraints violations and their average buried surface 
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area. The final structures are then clustered and analysed according to their average energy 
and then ranked.57-58  
2.1.3. Protein-protein interface predictors  
Knowing where on the surface protein-protein interaction occurs can limit the docking 
results and increase the chance of obtaining the correct conformation. Since the first 
protein-protein docking algorithm was published, many efforts have been made to 
theoretically predict the protein-protein interface.52
 
Even though, experimental studies 
suggested that the binding site of Sap-C should be in the proximities of the residue N370,42 
as its mutations affects the association, in our research we have resorted to one interface 
predictor in order to dismiss other possible sites of interactions.61
  
CPORT  
CPort is a consensus method for protein-protein binding site prediction, which combines 
the search of six different platforms for interface search.62
 
It makes use of different free 
algorithms, which combines and optimises the results. It uses two structure-based 
algorithm: Promate63 and SPPIDER64, one conservation based algorithm: WHISCY, a 
neural network Cons-PPSI,65 
 
and one empirical Scoring Function based: PINUP66. This 
algorithm was designed in the same group as Haddock, and it has been extensively reported 
to work better than all the rest separately.60 
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2.2. Experimental  
2.2.1. Protein-Protein Docking with Hex.  
Docking Optimization  
Two series of docking experiments were conducted to optimise parameters to perform 
protein-protein docking. In the first three experiments geometrical parameters were 
adjusted, which included angular and distance ranges. Those parameters that yielded better 
poses, in terms of distance between the partner proteins, number of electrostatic 
interactions and relative orientation of both proteins, were chosen to carry out a second 
series of optimization experiments, in which correlation type and post-processing 
procedure were evaluated in their different combinations.  
In Hex, the larger protein is defined as the Receptor, while the smaller protein is the 
Ligand.67 Here we have treated GCase as receptor and Sap-C as ligand. In order to limit 
the geometrical search of docking poses, Hex allows the user to adjust three geometrical 
parameters. Firstly, the distance range, which is the distance between the centroids of both 
proteins or the length of an intermolecular axis linking both centroids. Secondly, the angle 
range of the ligand and thirdly the angle range of the receptor that determines the degree 
of rotation of the protein relative to the defined axis. The range angles create imaginary 
cones that limit the rotational movement of the proteins.  
 
Table 2.1: First series of docking optimization experiments. Combinations of ranges that that 
produced best poses have been highlighted in red.  
Experiment Receptor Range 
(o) 
Ligand Range (o) Distance Range (Å) 
PARAMETER SET 1 45 45 20 
PARAMETER SET  2 60 60 40 
PARAMETER SET 3 75 75 40 
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As previously explained, Hex implements different algorithms for ranking solutions, which 
are termed as correlation types. Hex also offers multiple options of post-processing the 
docks. In the second series of experiments, different combinations of correlation types and 
post-processing parameters were used to optimise the results. A method unique to Hex 
employs the use of Decoys as a Reference State (DARS) to complete the docking 
information. DARS consists in a geometrical search after the interactions are compared 
and evaluated with decoys based on frequency of interactions.68
 
This method can also be 
implemented after correlations have been made using other ranking algorithms.  
Experiment CORRELATION TYPE POST-PROCESSING  
PARAMETER SET 1  Shape  No post-processing  
PARAMETERSET 2  Shape  Bumps  
PARAMETER SET 3  Shape  OPLS E  
PARAMETER SET 4  Shape  OPLS MM  
PARAMETER SET 5  Shape  DARS E  
PARAMETER SET 6  Shape  DARS MM  
PARAMETER SET 7  Shape + Electrostatics  Bumps  
PARAMETER SET 8  Shape + Electrostatics  OPLS E  
PARAMETER SET 9  Shape + Electrostatics  OPLS MM  
PARAMETER SET 10  Shape + DARS  Bumps  
PARAMETER SET 11  Shape + DARS  DARS E  
PARAMETER SET 12  Shape + DARS  DARS MM  
PARAMETER SET 13  Shape + Electrostatics + DARS  Bumps  
PARAMETER SET 14  Shape + Electrostatics + DARS  OPLS E  
PARAMETER SET 15  Shape + Electrostatics + DARS  OPLS MM  
Table 2.2: Summary of the second docking calibration experiments. Parameter Sets selected and 
chosen to be further refined has been highlighted in red.  
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These parameter sets resulted in docking poses where the relative location/orientation of 
the two proteins, and where a number of plausible side chain interactions were made, were 
selected to perform the rest of docking experiments.  
Docking experiments were conducted in combinations of different conformations of both 
partner proteins. For example, apo GCase (PDB id 1OGS25 and 2NSX.a27) and activated 
GCase (PDB id 2NSX.d27) were docked with closed (PDB id 2GTG38) and open 
conformation (PDB id: 2QYP69) of Sap-C. For each combination, two series of seven 
docking runs were carried out. In the first series, the centre of masses of each protein was 
used as a centroid or origin for all geometrical calculations. In the second series, residue 
H365 was selected as origin for GCase. The selection of H365 was based on the results of 
CPort algorithm and the results of experimental studies that locate Sap-C binding site in 
the proximities of the important residue N370. Using H365 as a centroid helped to narrow 
down the search in the GCase binding site, thus making the search more efficient (avoiding 
to test poses outside the binding site). It is important to note that the crystal structure with 
PDB id 2NSX has been used to test both Apo-GCase (2NSX.a) and activated GCase 
(2NSX.d). This is because the molecules in the asymmetric unit of this structure are 
different. The suffix at the end of the PDB id denotes the chain that has been used from the 
structure.  
 
 
Table 2.3: Second series of docking experiments, in which the centroid of the receptor protein was 
changed to residue H365. Calibration of geometrical parameters was recalculated for this series.  
Experiment Receptor Range 
(o) 
Ligand Range (o) Distance Range (Å) 
PARAMETER SET 1 45 45 20 
PARAMETER SET  2 45 60 40 
PARAMETER SET 3 45 75 40 
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Experiment  CORRELATION TYPE  POST-PROCESSING  
PARAMETER SET 1  Shape  Bumps  
PARAMETER SET 2  Shape + Electrostatics  Bumps  
PARAMETER SET 3  Shape + Electrostatics  OPLS E  
PARAMETER SET 4  Shape + Electrostatics  OPLS MM  
PARAMETER SET 5  Shape + Electrostatics + DARS  No post-processing  
PARAMETER SET 6 Shape + Electrostatics + DARS Bumps 
PARAMETER SET 7  Shape + Electrostatics + DARS  OPLS E  
 
Table 2.4: Parameters used for the first and second series of docking runs. A total of seven docking 
runs were conducted, each one with a different parameter set. In the first run the natural centres 
of masses of both molecules were conserved as centroid. In the second run the residue H365 was 
used as a centroid of GCase, whereas the natural centre of masses was used as a centroid of Sap-
C. 
 
2.2.2. Protein-Protein Docking with Haddock  
Six docking experiments were conducted using the “easy interface” of Haddock Server. 
Such interface allows the user to define the residues on the contact interface of both 
proteins. User may define “active residues” which will be taken to form a part of the 
interface and “passive residues” which will be considered to potentially be part of the 
interface.60 
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Table 2.5: Summary of the docking experiments carried out with Haddock. The active and passive 
residues have been chosen on the basis of the experimental data and predicted protein-protein 
interface from CPORT.  
 
2.2.3. Screening of docking orientations  
The screening of docking poses was conducted in several steps and was applied to the best 
20 solutions of each run: 
1. The quality of the docks was assessed, by taking into account the relative position 
of one protein with respect to the other. For example, poses in which Sap-C was 
encroaching the active centre or was too far away from it were rejected. This was 
carried out through simple visual inspection.  
 
GCase  GCase- Active Residues  
GCase- Passive 
Residues  SapC  
SapC- Active 
Residues  SapC- Passive Residues  
2NSX.d  H365  Auto  2GTG  
V49, T52, Y53, 
S56, S57, I60  Auto  
1OGS  H365  Q362, T369, Y373  2GTG 
V49, T52,Y53, 
S56, S57, I60  
 
K25  
2NSX.d  H365, T369  Auto 2GTG No V49, T52, Y53, S56, S57, I60  
1OGS H365, T369  Auto 2GTG  No  
N20, N21, K22, E24, E26, D29, 
S41, V49, T52, Y53, S56, S57, 
I60  
2NSX.d H365, T369 Auto 2QYP No 
N20, N21, K22, E24, E26, D29, 
S41, V49, T52, Y53, S56, S57, 
I60 
1OGS H365, T369 Auto 2QYP  No 
N20, N21, K22, E24, E26, D29, 
S41, V49, T52, Y53, S56, S57, 
I60 
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2. Interaction of the docked Sap-C with constituent amino acids present in the helix 7 
(of GCase) containing N370 was essential. Docks where this interaction was absent 
were rejected.   
 
3. Number of interactions between the two proteins was analysed in detail. Poses with 
less number of interactions were rejected.   
 
4. Only those docks in which Sap-C interacting residues corroborated with the 
experimental data were selected.   
The poses that satisfied the above mentioned criteria were energy minimised.  
 
2.2.4. Energy Minimisation with Amber.  
Hex performs a rigid body docking. Hence all resulting docking poses presented steric 
clashes between both proteins side chains, even after using post-processing procedures. In 
order to overcome this problem, the docks were energy minimised using AMBER1270 
software. 
The procedure used to minimise the structures was as follows:  
1. Create molecular topology/parameter and coordinate files with LeAP, using 
FF99SB all atoms force field for complexes with explicit solvent and counter-ions. 
 
2. Energy minimization of waters and counter ions by holding the protein complex 
fixed with positional restraints of 500 Kcal/mol, (1000 steps of minimisation). 
 
3. Energy minimization of the complete system without any restraints (2500 steps of 
minimisation).  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2.3. Results 	
2.3.1. Protein- Protein Interface Predictor  
The program used for predicting the protein-protein interface identifies the binding site of 
Sap-C on GCase to be between Helices 6 and 7 of Domain III and Domain II.
 
It is 
interesting to note that N370, is present on helix 7. This is consistent with experimental 
studies and is one of our criteria in selecting correct docked poses.  
 
 
 
Figure 2.2: The predicted protein-protein interface from CPORT algorithm. Residues in red are 
those considered by the program to take part in the protein-protein binding, and those marked in 
blue can potentially intervene in the bind. The program identified the protein-protein binding site 
over helix 7 of Domain III flanked by helix 6 and Domain II. 
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2.3.2. Docking Results  
3.3.2.1. GCase + Sap-C (Closed) 
Hex 
After applying the screening criteria to the top 20 clusters of output solutions for each 
docking, only six docked orientations of GCase and closed Sap-C were selected for energy 
minimisation.  
As mentioned in the introduction, the main difference between Apo- (inactive) and active 
structure of GCase is the different conformation of Loop-1. In inactive Apo-GCase, Loop-
1 shows an extended conformation whereas in active GCase the loop is in helical 
conformation. Except for Loop-1, the differences between apo- and active GCase are 
minimum. The cavity predicted to be the protein-protein binding site is similar in Apo- and 
active GCase. (The Cα-RMSD of the alignment between Apo-GCase (1OGS) and active 
GCase (2NSX.d) is 0.353 Å. The Cα-RMSD of the alignment between Apo-GCase 
(2NSX.a) and active GCase (2NSX.d) is 0.348 Å).  
The docking poses selected for energy minimization were aligned one against the other. It 
was seen that some poses could be considered similar. Although obtained with different 
combination of proteins (namely Apo-GCase and closed Sap-C and active GCase and 
closed Sap-C) the relative position of both proteins was almost identical, with the RMSD 
of the alignment of both poses being less than 0.6 Å. Table 6 summarises the poses 
considered for energy minimisation. 
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 MODEL Series Parameter set Docking Pose 
(cluster number) 
Pose 1 2NSXa-2GTG 1 5 4 
Pose 2 1OGS-2GTG 2 2 8 
Pose 3 1OGS-2GTG 2 2 1 
Pose 4 2NSXd-2GTG 1 6 3 
Pose 5 2NSXd-2GTG 2 1 1 
Pose 6 2NSXd-2GTG 2 1 8 
Table 2.6: Summary of the six poses (models) selected for energy minimization. Pose 1 and 3 and 
Pose 2 and 5 were almost identical.  
MODEL GCase- Residues Sap-C Residues HB and Ionic 
pairs 
2NSXa-2GTG-pose 1  
1OGS- 2GTG-pose 3 
F316-P319, K321, Q362, 
HY365, T369, Y373, 
K441, D443, R463-S465  
V14, L17, N21-T23, 
E26, I27, L29, A30, 
K33, M34, K37, E48  
K33-T369, D30- 
H365, K26-Q362, 
E14-K441  
1OGS-2GTG-pose 2 
2NSXd-2GTG-pose 5  
F316-P319, K321, K346, 
W348, R353, D358, Q362, 
H365, T369, Y373,D443, 
K441, R463-S465, Y487 
K25, E26, L29, A30, 
K33, M34, K37, S41, 
E44, E45, E48, T52, 
Y53, I57, V60  
K26-T369, D30- 
H365, K33-D315, 
Q48-D358, E25-
K441  
2NSXd-2GTG-pose 4  F316-P319, Y321, K346, 
W348, R353, S356, D358, 
Q362, H365, T369, K441, 
R463, Y487  
C4, E26, L29, A30, 
K33, K37, S41, E45, 
C46, E48, V49, T52- 
G54, L76  
T53-H365, E49-
R463, E45-S356  
2NSXd-2GTG-pose 6  
 
F316-P319, Y321, K346, 
W348, R353, D358, Q362, 
H365, T369, Y373, K441, 
D443, Y487, R463-S465 
T23, I27, 2E6, A30, 
F31, M34, K37, S41, 
E48, T52, S56  
K26-Y373, D30- 
Y369, D33-H365  
Table 2.7: Summary of the interacting residues in the selected models and relevant electrostatic 
interactions for selected poses of GCase and closed conformation of Sap-C.  
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Figure 2.3 A: Surface representation of the top docking poses that fulfil the selection criteria. Each 
docking pose has been depicted in two perspectives. Docking poses 1 and 2 have not been included 
as they are same poses as 3 and 5. GCase is shown in light green. Loop-1 at the entrance of the 
active site of GCase has been coloured in yellow and Loop-2 in purple. Helix 7 of GCase has been 
coloured in green. Sap-C is shown in cyan. GluCer has been represented as orange spheres. Pose 
3 has been illustrated in (a), Pose 4 has been illustrated in (b) 
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Figure 2.3 B: Surface representation of the top docking poses that fulfil the selection criteria. 
GCase is shown in light green. Loop-1 at the entrance of the active site of GCase has been coloured 
in yellow and Loop-2 in purple. Helix 7 of GCase has been coloured in green. Sap-C is shown in 
cyan. GluCer has been represented as orange spheres.  Pose 5 has been illustrated in (a) and Pose 
6 has been illustrated in (b). In the best pose, Pose 5, Sap-C fills the cavity formed by Loop-1 and 
2, helix 7 and Domain II of Sap-C. 
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Haddock  
None of the poses obtained from the first two runs of Haddock passed the first two selection 
criteria. Two poses from the third run passed the first two criteria but were not in agreement 
with the experimental data as both N- and C-terminal of Sap-C formed part of the binding 
site. It was when the predicted active and binding domains of Sap-C (N20, N21, K22, E24, 
E26, D29, S41, V49, T52, Y53, S56, S57, I60) were coerced as passive residues when we 
observed one of the poses already obtained with HEX. The identified dock was very similar 
to the docking poses 2 and 5 from HEX experiments. The RMSD of the alignment was 
0.62Å.  
 
Figure 2.4: Superposition of the complexes obtained from Hex- pose 2 (second series, eighth 
docking pose) in light blue and one of the poses obtained from the third run of Haddock in red. 
Both complexes share the same relative position of the pair of proteins. 
 
Due to the consistency with experimental data, the correspondence across different docking 
algorithms and the concordance of the binding mode when two different conformations of 
GCase were used, we selected Pose-2 (extended) and Pose-5 (helical), for further studies. 
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2.3.2.2. GCase + Sap-C (Open) 
Hex 
We first analysed the results of the docking experiments that were run using the open 
conformation of Sap-C. Even though the final pose that was selected was the only pose that 
satisfied experimental data, as well as the only one found using two different docking 
methods and two different conformations of GCase, we were receptive to find new and 
better models. We also identified an equivalent pose with the open conformation of Sap-
C, in some of the docking runs. Finally, we selected two docking poses to represent our 
model, which are summarised in Table 2.8 and 2.9. 
 MODEL Series Parameter set Docking Pose     (cluster 
number) 
Pose 7 1OGS- 2QYP 1 2 3 
Pose 8 2NSX.d-2QYP 1 5 7 
 
Table 2.8: Summary of the two poses (models) selected for energy minimization. Pose 1 and 2 were 
almost identical. 
MODEL GCase- Residues Sap-C Residues HB and Ionic pairs 
Pose 7- 1OGS- 2QYP 
Pose 8- 2NSX.d-2QYP 
D315- K321, K346-E349, 
R353, D358, Q362, 
H365, Y373, D443, 
K441, D443- D445, 
R463-S466, Y487 
K25, E26, L29, A30, 
K33, M34, K37, S41, 
E44, E45, E48, T52, 
Y53, I57, V60  
Q48-W348, K26-Q362, 
D30- H365, E25-K441, 
D443- S60, N22- D445, 
S57- 466 
 
Table 2.9: Summary of the interacting residues in the selected models and relevant electrostatic 
interactions for selected poses of GCase and open conformation of Sap-C.  
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Figure 2.5: (a) Alignment of 2NSX.d-2GTG-pose 5 and 2NSX.d-2QYP-pose 8. The figures illustrates 
GCase in complex with Sap-C in open (green) and closed (cyan) conformation. GCase has been 
depicted in surface representation and coloured in light brown. (b) 2NSX.d-2QYP-pose 8, GCase 
(light brown) in complex with closed Sap-C (green). (c) 2NSX.d-2QYP-pose 8, GCase (light brown) 
in complex with closed Sap-C (cyan). GlyCer is drawn as orange spheres. 
 
 
a 
b c 
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2.4. Discussion  
The GCase-Sap-C model presented by Atrian et al. in 2008 is valuable, although not in 
complete agreement with the experimental data.46 Besides, this model is not available in 
the public domain. In the work presented in this thesis, we have followed a knowledge-
based docking protocol to identify the GCase-Sap-C protein-protein interface.  
It is important to point out contradicting data between experimental studies, on Sap-C 
interface with GCase. Weiler et al. based their study on competition of synthetic peptides 
derived from Sap-C, located two binding sites at position 6-27 and 45-60, and two 
activation sites at position 27-34 and 41-48 on Sap-C45, judging by the capacity of these 
peptides to bind or activate GCase hydrolysis of a fluorescence GCer analog (4-
methylumbelliferyl-𝛽-D-glucoside. Another study by Qi et al., based on chimeric saposins, 
pointed just one activation site between residues 47- 62.43 Spatially positioning the sites on 
the structure of Sap-C, we immediately observe that all the data cannot be reliable. Binding 
site 1 and 2 from Weiler et al. is not compatible as they are on opposed edges of the protein. 
Comparing the results of the two studies we inferred that:  
1. There is an observed coincidence in the predicted activation site proposed by Qi et 
al. and the second binding site observed by Weiler et al. In fact, they are same. So 
if we have to choose one binding site then it has to be the preferred one.   
2. The second binding site identified by Weiler et al. binds with stronger affinity, so 
is more likely to be the binding site.  
3. The first binding site is not compatible with the membrane anchoring experiments 
(see chapter 3).   
Based on these criteria, we started looking for the second binding site suggested by Weiler 
et al (residues 45-62) on helix 3 of Sap-C. It was most likely to be the binding interface 
with GCase. Furthermore, the two activation sites proposed by Weiler (helix 2 and 3) and 
that proposed by Qi (helix 3 and 4) are topologically compatible with the second binding 
site. We therefore conclude that helices 2, 3 and 4 of Sap-C should constitute the protein-
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protein binding interface.  
  
 
Figure 2.6: The structure of Sap-C. (a) The binding site (residues 6-27 and 41-60; orange) and the 
activation sites (27-34 and 40-49; red) as proposed by Weiler et al.
 
and (b) The activation site as 
proposed by Qi et al. (47-62; red) has been illustrated. Please note that the protein Sap-C is 
composed of 5 helices and not just four as it could seem at first glance. Helices 3 and 4 are 
separated by a kink instead of a loop. 
One can now think of two possibilities for selection based on the experimental observation 
of activation by Sap-C:  
1. The two activation sites identified by Weiler et al. lie adjacent to the loops at the entrance 
of the active site of GCase and exerts its actions on the surrounding environment.  
2. The activation site of Sap-C defined by the Qi et al. lies adjacent to the loop at the 
entrance of the active site of GCase.  
At first instance, we thought that the second option would probably be the answer. We 
thought so because the activation site proposed by Qi et al. coincided with the second 
binding site proposed by Weiler et al. We oriented the proteins such that the activation site 
proposed by Qi et al. was positioned in the proximities of the loops at the entrance of the 
active site. We also defined this site as active and passive residues in the Haddock program 
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(see Table 2.5). We identified only one pose that was consistent with our selection criteria. 
However, we were unable to identify a similar docking pose via Hex.  
A pose in agreement with the first criteria was identified via Hex. It was found in both 
cases, when activated and apo- conformations of GCases were used. This pose was also 
identified in results from Haddock, albeit being the only plausible pose. Interestingly, the 
pose was obtained with Haddock only after we stopped coercing a binding site that satisfied 
the second criteria (see Table 2.5). We also found a GCase-(Open) Sap-C model in this 
orientation. 
Apart from the aforementioned experimental data about the binding and the activation site 
in Sap-C, we relied on the solved crystal structure of a Galactocerebrosidase (Galc) and 
Saposin A (Sap-A) complex.71 Galc is another lysosomal hydrolase that catalyses the 
cleavage of galactocerebrosides. The overall fold of Galc is very similar to the structure of 
GCase, and it comprises of three domains: Domain I, a (𝛼/𝛽)8 TIM Barrel containing the 
binding site equivalent and highly similar to Domain III in GCase; Domain II, a 𝛽- 
sandwich that present a similar topology to Domain II in GCase; and Domain III, a lectin 
Domain that has no equivalence in GCase.  
The protein binding site in Galc lies between Domain I and III, within the proximities of 
the active site.69 Although Galc shares an overall common structure with GCase there are 
some key features that make the protein surfaces rather different. Firstly, one of the loop 
of the 𝛽 – sandwich domain wrap over the active site constituting, probably, an activation 
loop. This loop changes the equivalent cavity formed in GCase between helices 6 and 7 
and Domain II. Secondly, Domain III (lectin domain), absent in GCase, provides support 
for the binding of the cofactor, drawing a subtle cavity with some of the loops of the N-
terminal side of the TIM Barrel. GCase lacks this cavity. Thirdly, even though both 
enzymes share the TIM Barrel motif, the loops at the entrance of the binding site are rather 
different in both proteins. The longest loops in Galc are found in the C-terminus side of the 
molecule, whereas the catalytic residues (E258 and E182) are exposed.72 Figure 2.8 
illustrates the crystal structure of the complex alone and aligned with our model of GCase 
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and Sap-C. 
In 2006, the crystal structures of Sap-C and Sap-A were solved in a study carried out 
Victoria E. Ahn et al.38 This study pointed out the differences in the electrostatic surface 
of both proteins, attributable to their different function. In 2001, Gregory A. Grabowski 
had already reported the different lipid binding properties of both proteins and correlated 
them with a different mechanism of action and different activation domains.73 The different 
binding modes to the membrane are shown in Figure 2.7. 
The differences in the structure and electrostatic surface between GCase and Galc, and 
Sap-C and Sap-A, the disparity in the activation domains of both cofactors, as well as the 
different binding properties, made us think both complexes, namely, Galc-SapA and 
GCase-SapC could be somehow different although with some common features. Those 
shared characteristic of the protein-protein binding site would be for example, lying beside 
the active site of the enzyme without encroaching it, being in agreement with the membrane 
interaction experiments or with the experimental determination of the activation domain. 
 
 
 
Figure 2.7:  The membrane binding mode of (a) Sap-C and (b) Sap-A. It can be seen that, even 
though both proteins have a high structure similarity, their mode of interaction with the membrane 
is different. Taken from reference 71. 
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Figure 2.8: (a) Crystal structure of Galc (PDB ID: 5NXB71). Domain I is depicted in green, 
Domain II in orange and Domain III in red. (b) Crystal structure of Galc in complex with Sap-A 
(purple) (PDB ID: 5NXB). (c) The crystal structure of Galc in complex with Sap-A has been aligned 
with the crystal structure of GCase (cyan). (d) The crystal structure of Galc in complex with Sap-
A has been aligned with the crystal structure of GCase (cyan) in complex with Sap-C (yellow). 
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Here we present this protein-protein model that has been obtained using the first criteria 
(based on the two activation sites identified by Weiler et al., lie adjacent to the loops at the 
entrance of the active of GCase and exerts it actions on the surrounding environment) and 
that in our opinion fulfils all the requirements to be a good pose and it is in agreement with 
the experimental data.  
 
Figure 2.9: (a-b) Two different views of the predicted GCase-Sap-C complex. GCase is shown as 
a cartoon in light green: Loop-1 in yellow, Loop-2 in purple and Helix 7 in dark green. Sap-C is 
shown as a surface, the binding site (residues 6-27 and 41- 60; orange) and the activation sites 
(27-34 and 40-49; red) as proposed by Weiler et al.
 
and the rest of Sap-C in turquoise.  
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CHAPTER 3: MOLECULAR DYNAMICS  
3.1. Introduction  
The Function of biological macromolecules stems from their three-dimensional structure. 
Molecular dynamics (MD) simulations provide a valuable way to understand the physical 
basis of conformational changes that macromolecular structures undergo and that, 
ultimately, lead to the their biological function.74,75 The internal motions determined by the 
structure produce the conformational dynamics of proteins critical to their function. 
Therefore, the connection between spatial structure and dynamics is necessary for the 
comprehension of protein functionality.72-76 
The traditional way to explore conformational changes in proteins, so as to understand their 
biological function, was to accumulate many experimental structures that would cover the 
conformational space.77 The rapid development of computer power in the seventies,  
allowed to approach the proteins conformational changes in a dynamic way by letting all 
the atoms in the macromolecule interact for a period of time. Thus, molecular dynamics 
simulations started to provide a connection between structure and dynamics turning into 
an interesting tool to explore the conformational energy landscape accessible to 
biomolecules.72,73 
Molecular dynamics simulations offer atomic detail of the evolution of a system as a 
function of time, difficult to reach through experimental techniques; thus this theoretical 
technique can provide a complete picture of the dynamic features of the system and answer 
specific questions about the structural mechanism of action of proteins.78 
In this context, we used molecular dynamics simulations to understand the structural 
mechanism of function of the enzyme GCase, to explore its structural dynamics and 
conformational changes that promote or are promoted by the interaction with other 
components including its facilitator protein, lipid membrane, etc. The evaluation of the 
protein dynamics offered complete understanding of the role of each part of the protein and 
thus provided structural implications of different mutations. A molecular dynamics 
simulation is the only method that allows us to study the dynamic interactions between the 
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proteins GCase and Sap-C and them with the membrane.
  
3.1.1. Molecular dynamics: Theory  
Molecular dynamics simulations could be used to study the evolution of the internal 
motions of a protein and can also produce detailed thermodynamic and kinetic 
information.76 Molecular dynamics simulations provide information at the atomic level like 
velocities and coordinates of atoms, this information can be converted, via statistical 
mechanics, to macroscopic observables, quantifiable properties such as heat capacities, 
energy and pressure. Statistical mechanics provides the mathematical foundation to relate 
atomic motion and distribution data to macroscopic properties, usually defined in terms of 
time-independent statistical averages. Thus, statistical mechanics is able to predict 
macroscopic phenomena of a biological system from individual molecular properties.72-74,79 
Since the development, in the twentieth century, of the theory of the quantum mechanics 
(QM), the dynamics of the particles can be described by a new equation of motion, namely, 
the Schrödinger equation.77 Molecules could potentially be described in terms of 
interactions of the nuclei with the electrons, whereas molecular geometry can be described 
as energy arrangements of nuclei. The Schrödinger time- independent Equation could be 
solved for a hydrogen atom through following equation.77 − ℏ{	Wq	∇W − }y	 	𝜓 𝑅 = 	𝐸𝜓(𝑅)                     (3.1) 
In this equation, the term in the square brackets represents the potential and kinetic energy 
of the electron; the distance of the electron from the nucleus is represented by r and the 
charge of the nucleus by Z. ∇ is the Laplacian operator (sum of second derivatives of the 
function with respect to each independent variable). ℏ	is the reduced Planck constant 
(ℏ =h/2π).  The 𝜓 is the state or wave function representing the coordinates of the electron, 
the E represents the electronic energy in atomic units and the R represents electron 
coordinates. The wave function for hydrogen atoms are essentially the atomic orbitals: s, 
d, p …  
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The Schrödinger equation can be generalised to a multinuclear, multi-electron system, as 
follows:77 
                                                       	HΨ = EΨ                                  (3.2) 
In above equation, the Ψ is the multi-electron wave function H is the Hamiltonian 
operator, which is: 
Η = −12 ∇\W]]vywlx\ − 12 1𝑀H
l]\
H ∇HW − 𝑍H𝑟\H
l]\
H
]]vywlx
\ + 							 1𝑟\
]]vywlx
\ + 𝑍H𝑍I𝑅HI
l]\
HI 									 
(3.3) 
Where Z is nuclear charge, MA is the ratio of mass of nucleus A to the mass of an electron, 
RAB is the distance between the nuclei A and B, rij is the distance between the electrons i 
and j and riA is the distance between electron i and nucleus A. 
However, the Schrödinger equation has never been solved for a multi-electron system, not 
even for a two electron system such as the hydrogen molecule or the helium atom.75,77 So 
that, in order to describe the dynamics of a complex biological system, an approximation 
to the Schrödinger equation needed to be introduced. One of the most used methods to 
study the dynamics of biomolecules is the Born-Oppenheimer approximation.80 This 
approximation to the Schrödinger equation relies on the dramatic difference of mass 
between electrons and nuclei.81 The electrons are much lighter and hence move much faster 
than the nuclei, so that they rapidly adapt to the position of the nuclei. Thus, the motion of 
the electrons can be neglected allowing the dynamic to be decoupled in two subsystems, 
one slow subsystem, the nuclear, and one fast that follows the state of the former (electron). 
In practise, the use of this approach allows the nuclei and electrons to be quantified into a 
sole atom-like particle.75-82  
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3.1.1.1. Molecular Mechanics: Force fields.  
The forces acting on atom-like particles are computed using Molecular Mechanics force 
fields. Unlike Quantum Mechanics, Molecular Mechanics quantify the energy of the 
particles based on their atomic entities, nuclei and electrons being unified.83 Force fields 
are mathematical concepts that combine first-principles physics and parameter fitting to 
quantum mechanical calculations and empirical data to define molecules, represented as 
atoms connected by bonds with lengths, angles and energies.84 There are different types of 
force fields developed with different levels of complexity designed to be used for different 
systems, schematically a force field being: 
 
E TOTAL= E Stretch + E Angle + E Torsion + E VdW + E Electrostatics     (3.4) 
This simplified equation represents the total sum of energies exerted over a particle in a 
macromolecule. The total energy is the sum of bonded (E Stretch + E Angle + E Torsion) and non-
bonded interactions (E VdW + E Electrostatics).85,86 
Molecular Mechanics considers molecules as weights connected by strings.86 The potential 
energy of the stretch and angles of the bonds are calculated through the Morse potential 
and Harmonic potential, respectively, the latter being derived from the Hooke’s law 
(Harmonic Oscillator Model).87However, Morse potential is not normally used in 
molecular mechanics force fields, a simpler approach is to use Hook’s law in which the 
energy changes are based on square dislocation from the reference bond length, which is 
known as l0 and k being bond constant, as shown in equation 3.5.83-85 																																																																		𝜐 𝑙 = pW (l	– 	l0)2                (3.5) 
The angle bending is treated the same manner as bond stretching using Hook’s law through 
the deviation of the angles from a reference angle via the following equation: 83-85 																																																																		𝜐 𝛩 = pW (Θ	– 	Θ0)2                                               (3.6) 
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Where Θ0 is the reference angle and k is the force constant. It is estimated that a smaller 
energy is required to move the angle from the reference or equilibrium than to stretch a 
bond. 83-85 
In bond stretching and angle bending the creation of any change or deformation from the 
equilibrium requires a large energy input, so that the main difference in structures and 
energies are due to the torsional and non-bonded interactions. The structural elements as 
well as the molecular geometry could be easily understood by defining the existence of 
barriers to rotation about bonds. The energy of torsion considers the periodicity of rotation 
in bonds. 83-85 
𝜐 𝜔 = cWglm [1 + cos 𝑛𝜔 − 𝛾 ]    (3.7) 
Torsional potentials are mostly represented as a cosine series expansions. Vn is the barrier 
height, 𝛾 determines the barrier where the torsion angle crosses its minimum value and the 
ω is the torsion angle. 83-85 
 
 
 
Figure 3.1: represents the bonded interactions in the model of molecules as weights and bonds: 
(a) bond stretching,  (b) angle bending and  (c) dihedral angle torsion. 
 
The corresponding energies of van der Waals and electrostatic interactions are calculated 
by Lennard Jones Potential and Coulomb’s Law respectively.87 
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Figure 3.2: Potential Energy curve for the Lennard-Jones Potential, which represents the long 
range of attractive forces that holds atoms together. 
As seen in Figure 3.2, at the equilibrium distance the net force is equal to zero and the 
potential energy is minimum. For separation smaller than equilibrium distance repulsive 
forces start to take effect and the potential energy increases up to the collision diameter 
(σ).88,89 
The electrostatic interactions represent a long range of attractive (or repulsive, depending 
on the charges) forces which become slowly weaker as a function of 1/r (Eq. 3.8). The 
Lennard Jones potential includes two terms one for long-range attractive interactions (van 
der Waals and dispersion interactions) that are function of 1/r6 and the other for the short-
range of repulsive interactions 1/r12 (overlapping electron orbitals) (Eq. 3.9).83, 85-87 
𝐸[R[PQXPHP		 = 	 ayaguvwqx\guvwqx\      (3.8) 
Equation 3.8 expresses Coulomb’s law in which qi and qj are the atomic charges of the 
atoms i and j respectively, r is the distance between atoms and D is proportional to the 
dielectric constant of the material that surrounds the charges (e.g. water). 
CHAPTER 3: MOLECULAR DYNAMICS 
	
 74 
𝐸		 = 	 Hayas{ − Iayafguvwqx \guvwqx\      (3.9) 
Equation 3.9 expresses the Lennard Jones potential, the parameters 𝐴\	and 𝐵\are the van 
der Waals constants (determined experimentally or through modelling) and rij corresponds 
to the separation radius between the atoms i and j.86,87 
So that, a typical potential energy function from a Molecular Mechanics force field would 
have the following form:85 
𝑈 = UW¤wl_x 𝑘¤(𝑟 − 𝑟)W + UWul¥]x 𝑘¦(𝜃 − 𝜃)W + ¨cWvwyx\wlx 1 + cos 𝑛𝜔 − 𝛾 +	+	 Hayas{ − Iayafguvwqx \guvwqx\ + aya]]     (3.10) 
The equation 3.10 defines a general Potential Energy function as the implemented by a MD 
algorithm. Each one of the terms in this equation has been already explained thoroughly.  
3.1.1.2. Molecular Dynamics Algorithm.  
Molecular Dynamics solves Newton equations of motion to calculate the atom 
trajectories.76 First, the potential energy is calculated for each atom. Then, the force to 
which each atom is submitted to, thus, obtained as a first derivative of the potential energy 
function with respect to the atomic position. The change in position of the atoms as a result 
of the forces exerted over them is calculated for each increment of time. The position is, 
therefore, obtained in each increment of time, atom trajectory being drawn along the 
simulation.5,72-76 
Molecular dynamics algorithms take initial atom positions and initial distributions of 
velocities as input.73-76 The force exerted over an atom can be calculated deriving the 
potential energy function with respect to the atom position: 
Fi  =  −©ª()©ya       (3.11) 
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As the second Newton’s equation: 
Fi = mi ai or Fi = 𝑚\ 	©{«¬	©v{	  ;     Then,  −©ª ©y\ = 	𝑚\ 	©{«¬	©v{	      (3.12) 
U represents the potential energy based on the coordinates of the n atoms and the equation 
has to be solved numerically using a suitable algorithm.74,5 This numeric solving is done 
through discretization of the trajectory and uses an integrator to move forward the 
trajectory over small steps or frames:  𝑟\ 𝑡 → 𝑟\ 𝑡 + Δ𝑡 → 𝑟\ 𝑡 + 2Δ𝑡 → ⋯	𝑟\(𝑡 + 𝑛Δ𝑡)		 	 (3.13) 
The atomic position can be obtained for time step (Δt) using the following equation 
ri (t + Δt) = ri (t) + vi Δt + 
UWai (Δt)2     (3.14) 
Thus, atoms position is obtained every time step. All atoms positions in the protein are 
calculated simultaneously, for every time step. The variation in atomic positions along the 
time draws a trajectory, which ultimately allows us to know the evolution of the biological 
system along time. 5,72   
These integrators possess properties such as high accuracy, stability if large Δt is used and 
speed for force calculations.	 These algorithms are simple, efficient, stable and time-
reversible which provide good choice as integrators for MD simulations. 5,72-76 
 
3.1.2. Energy Minimization 
The conformations of a macromolecule can be defined as the different arrangements its 
atoms can adopt in the Cartesian space, when they are repositioned through all their degrees 
of freedom. An N- dimensional potential energy surface is, thus, created where N are the 
molecular degrees of freedom. Many factors contribute to the creation of such hyper-
surface including angle bending, torsional allowance around rotatable bonds, bond 
stretching and interatomic contacts. Energy Minimization (EM) algorithms sample the 
conformational space trying to find that with the lowest potential energy, or the deepest 
point of the hyper-surface. The reason for this is to optimize the molecular geometry prior 
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to an MD simulation through elimination of undesired interactions or non-physical 
contacts.90,91 
However, the potential energy surface contains multiple minima. The deepest point in the 
surface is called global minimum; yet it contains multiple local minima or substates. 
Between minima there are humps or saddles that represent conformations of greater energy 
that have to be sampled to reach the following minimum. Ideally the global minimum is 
pursued, but in the practice, it is impossible to sample the whole conformational space in a 
reasonable amount of time and the arrival to the global minima is never guaranteed. In 
many cases the algorithm just aspires to a certain threshold of Energy/Forces.88-92
 
 
3.1.3. Solvation of the system  
It is widely accepted that the inclusion of solvent is indispensable to reproduce some 
properties of soluble biomolecules.93
 
In an MD simulation, the solvent can be added as a 
continuum medium (implicit solvation) that intends to emulate the solvent in energy 
terms.94
 
Another way of including solvent in the simulation is by adding discrete particles 
of water explicitly. Although the inclusion of explicit waters consumes much more 
computational power, it has been demonstrated how the solvent may influence internal 
motions and functionality of macromolecules.95 
Calculation of all the forces produced in a bulk of solvent can be computationally 
expensive, therefore must be limited. Simulation in a water box outside of which is vacuum 
may not reproduce properly the properties of the bulk and cause artefacts or solvent 
molecules may be lost during the simulation. To avoid these problems MD programs 
employ what is called “Periodic Boundary Conditions”.96 
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3.1.4. Periodic Boundary Conditions  
Periodic Boundary Conditions (PBC) reproduces the simulation box (unit cell) in the three-
dimensional space creating an infinite 3D-array. Only the content of one cell is simulated 
but the effects of the particles interacting with the close particles in neighbouring cells are 
reproduced through the whole periodic array. If one particle escapes from the box it will 
enter again through the opposite site side of the cell, so that, the number of particles remains 
constant throughout the simulation.97 
 
Figure 3.3: Periodic boundary conditions are shown in two dimensions. Only the content of the 
central cell is simulated, but its content is reproduced in the periodic array so as to capture those 
particles leaving the cell. 
3.1.5. Pressure and Temperature Coupling.  
MD methods also implement algorithms that maintain and/or modulate pressure and 
temperature in the simulated system. An ensemble can be defined as a thermodynamic 
state. MD simulations employ the microcanonical ensemble (NVE). Such ensemble is 
characterised by a constant number of molecules (N), a constant volume (V) and no energy 
exchange (E). NVE ensemble corresponds to an adiabatic process where there is not 
exchange of energy with the exterior, only potential and kinetics energy exchange inside 
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the system. There are number of reasons why the conditions of the simulation need to be 
changed: over-heating that causes frictions and calculus errors. Maintaining constant 
pressure and temperature can emulate the lab and biological conditions.92,98,99
  
In the canonical ensemble or NVT, the temperature is constant during the whole simulation. 
A thermostat allows the energy to be exchanged, corresponding this to an isothermal 
process. However, the ensemble that best reproduces lab conditions is called NPT 
ensemble, since the number of molecules (N), temperature (T) and pressure (P) remain 
constant. A barostat is included that allows a modulation of the box size to maintain a 
constant pressure along the run. This last ensemble would then correspond to an isothermal 
and isobaric process.90,97
  
3.1.6. Coarse- Grained Molecular Dynamics.  
Some processes in nature occur above the time-scale that can be reproduced by MD  
simulations  in a reasonable computing time (ns to 𝜇𝑠	timescale), protein folding or lipid 
self-assembly, are among these processes .
 
Simplified description of the biological system 
can be used to accelerate the MD run. The Coarse-grained (CG) models group atoms in 
coarse particles, so that the degrees of freedom are reduced to speed up the simulation.100,101 
One of the biological process that can be very computationally expensive, and on the other 
hand is not necessary to be studied in atomistic detail, is the lipid membrane self-assembly. 
This process usually occurs in the microsecond timescale.
 
When mixed in solution, 
amphipathic phospholipids tend to associate in ordered phase in a process driven by the 
hydrophobic effect. As we are working with membrane proteins of which we do not have 
previous knowledge of how they interact with the membrane, we follow the process of 
membrane insertion via self-assembly. In these simulations, the membrane components are 
allowed to self-assemble in the same system the protein is solvated.102,103  
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3.1.6.1. Martini Force-Field  
Martini has been our force field of choice to conduct the CG simulation.104
 
Martini groups 
atoms in clusters of four atoms called “beans”. It considers four bean types regarding their 
physico-chemical properties, namely: Charged (Q), Polar (P), Non-polar (N) and Apolar 
(A). Each one of those particles has subtypes, so that the properties can better outline the 
physical profile. For example, the capacity of forming hydrogen bonds is denoted by 
letters, namely: donor (d), acceptor (a), both (da) or none (0). Or the level of polarity is 
denoted by numbers, 1-5.105,106,104 
Martini force field can be implemented in Gromacs, and it is very similar to Gromos force 
field but the calculations are adapted to the big beans. After the simulation, atomic-scale 
detail can be obtained by back conversion of CG beans to their atomistic coordinates.102-
104 
3.1.7. Gromacs  
We have chosen Gromacs to be our preferred MD engine to perform our simulations. 
Gromacs implements different atomistic force fields. Gromos force field was designed by 
the creators of Gromacs and used to conduct atomistic MD simulations in this project. 
107,108 
Gromos is an atomistic force field that uses united-atoms particles to describe biomolecular 
systems, in which non-polar hydrogens are treated as part of the neighbouring heavier 
atoms. 105, 106 
The particulars options of simulations that Gromacs have to offer and how we carried out 
our simulations will be explained in the section of methods. 
 
 
 
CHAPTER 3: MOLECULAR DYNAMICS 
	
 80 
3.2.  Experimental  
 
3.2.1. Coarse- Grained Molecular Dynamics (CG-MD)  
In order to study the insertion of the proteins in the membrane we carried out five CG-MD 
simulations, employing the Martini force field.  
SIMULATION SYSTEM PDB ID LENGTH 
(𝝁𝒔) DPPC WATERS 
1- GG GCase 1OGS 1.20 300 5000 
2- CG GCase + GluCer 1OGS 1.20 338 6431 
3- CG CPX 2NSX + 2GTG     
(pose 5)  
1.20 414 8500 
4A- CG Sap-C (closed) 2GTG 1.20 250 4000 
4B- CG Sap-C (open) 2QYP 1.20 250 4000 
 
Table 3.1: Summary of the CG-MD carried out in this study. Five different systems were inserted 
into the membrane via self-assembly simulations. They included (1) GCase, (2) GCase bound to its 
natural substrate, (3) GCase bound to Sap-C and GluCer, and (4) Sap-C.  
The atomistic models were converted using the script “Martinize” obtained from the 
Martini website.
 
A box of DPPC (Dipalmitoyl Phosphatidyl Choline) lipids was generated. 
DPPC is the most widely form of Phosphatidyl Choline (PC), the majoritary component of 
the lysosmal membrane.109 The optimum numbers of lipids for each system were identified 
using trial and error. This was followed by 1000 steps of steepest descent energy 
minimisation. The systems were then solvated and energy minimised until the desired 
proportion of water/DPPC lipid ratio was obtained. The energy minimisation in those 
cycles was conducted in two consecutive steps employing the steepest descent and 
conjugate gradient (1000 cycles) algorithms. Finally, the molecular dynamics simulations 
were run for 1.2µs with a time step of 0.003 ns, employing Berendsen temperature and 
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pressure coupling. CG-MD was performed in Gromacs using Martini force field. The 
simulations were run on the UCL Legion Super Computer cluster using 24 CPUs.  
As shown in Table 3.1, in simulations 2 and 4, Glucosylceramide (GluCer) substrate was 
used. The CG parameters for GluCer were obtained from the Martini website.
 
The substrate 
was manually positioned in the active site, using atomistic coordinates as a reference. The 
lipid tails were extended as the parameters obtained from Martini website account for a 
molecule with smaller acyl tails.  
3.2.2. Atomistic MD (AT-MD) 
In order to study our system to atomistic detail we carried out 10 atomistic simulations, 
including complexes of the two proteins and mutants. The simulations are summarised 
below. 
SIMULATION SYSTEM a b N.Atoms AT (ns) 
1 GCase - IN 20070 500 
2a GCase + GluCer ACT  22084 1000 
2b GCase + GluCer  IN 22082 1000 
3a CPX ACT  26540 1000 
3b CPX  IN 26537 1000 
4 SAP-C - - 13242 500 
5a CPX (N370S) ACT - 26536 1000 
5b CPX (N370S)  IN 26536 1000 
6a CPX (L444P) ACT - 26535 1000 
6b CPX (L444P) - IN 26535 1000 
 
Table 3.2: Summary of the AT-MD simulations conducted in this project. In some cases the systems 
were converted to atomistic detail using both (active/helical and inactive/extended) conformations 
of the protein GCase. i.e. In simulation 2a the active form of GCase has been used for conversion 
from CG to MD and in simulation 2b the inactive form of GCase has been used for conversion. 
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AT Parametrization 
 Force field compliant topologies were generated using the proteins of the converted 
models. GluCer was added in those simulations where it was required by aligning the 
converted models to the docked structure. CG models were converted using the same AT-
coordinates that were used to create them. The converted models were, in some cases, used 
to obtain different conformations/ mutants of GCase by aligning to the desired structures. 
The AT conversion of Simulation 2-CG was used to obtain the coordinates for Simulation 
2a and 2b, Simulation 3-CG was used to obtain the coordinates for Simulations 3a and 3b, 
Simulations 5a and 5b and Simulations 6a and 6b. 
AT-MD 
The models were solvated using Single Point Charge water (SPC), the default solvent in 
Gromacs. They were energy minimised using 5000 steps of steepest descent method. 
Counter ions were also added to neutralise the systems. A second round of energy 
minimisation cycle was conducted employing an additional 5000 steps of the steepest 
descent method.  
Two rounds of equilibration were carried out: Firstly, 0.1 ns of NVT equilibration with 
time steps of 0.002 ns, using V-rescale algorithm for temperature coupling. The 
temperature was coupled separately for protein/ complexes, lipids and solvent at 323 K and 
using a time constant for coupling of 0.1 ps. This was followed by 1 ns of NPT equilibration 
with a time step of 0.002 ns, using Nose- Hoover temperature coupling and Parrinello-
Rahman for pressure coupling. The temperature was coupled separately for protein/ 
complexes, lipids and solvent at 323 K and using a time constant for coupling of 0.5 ps. 
The pressure of the system was coupled semi-isotropically using Berendsen algorithm at 1 
bar, a compressibility of 4.5e-05 and a time constant for coupling of 5.0 ps.  
The production run was carried out for 500/1000 ns without any restraints with a time-step 
of 0.002. A cut-off of 12 Å was chosen for the neighborlist generation and the Coulomb 
and Lennard-Jones interactions. Particle-Mesh-Ewald summation was chosen for 
electrostatic interactions. Nose- Hoover was selected for temperature coupling and 
Parrinello-Rahman for pressure coupling. The temperature was coupled separately for 
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protein/ complexes, lipids and solvent at 323 K and using a time constant for coupling 
of 0.5 ps. The pressure of the system was coupled semi-isotropically using Berendsen 
algorithm at 1 bar, a compressibility of 4.5e-05 and a time constant for coupling of 2.0 ps. 
For those systems with two proteins or that included the substrate, strong position restraints 
were applied for energy minimisation runs and soft restraints for equilibration phase 
simulations. The production run was carried out without any restraints on the system. 
Mutants 
Mutant proteins were generated using the molecular modelling package ICM-Pro 
(www.molsoft.com)110, using the same PDB structures as for the rest of the models. The 
mutant simulations were set up by converting CG structures of the complex  (3-CG) to 
atomistic detail, using the mutated proteins instead of the wild type. The simulations were 
detailed in, Table 3.2. 
Analysis 
The simulation data was analysed in interactive python using the modules: mdtraj111, 
numpy112 and matplotlib113. Gromacs analysis suite was also used as an analysis tool. 
VMD114 was used for visualising the trajectories. Pymol115 was used to produce 
electrostatic surfaces. The figures were made using Pymol115, ICM-Pro110 and VMD114.   
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3.3.Results. 
3.3.1. Coarse- Grained Molecular dynamics simulations.  
Self-assembly coarse-grained simulations have been extensively used to study the 
orientation of proteins in the membrane105. The main goal of the coarse grained simulations 
was to understand how the protein/complexes associated within the membrane.  
Between 40-120 ns all the membranes were assembled. To confirm if the self-assembly 
process has been successful, we calculated the area per lipid in the bilayer. The 
proteins/complexes were inserted in to the lipid membrane immediately after their 
formation and remain anchored throughout the course of the simulation. The CG-MD 
simulation results suggest that the membranes were well formed and equilibrated.  
 
 1-GCASE-GC 2-GCASE-
GLUCER-GC 
3-CPX-GC 4A-SAP-C-CG 4B-SAP-C-CG 
AREA PER 
LIPID 
(NM2) 
0.645 0.651 0.640 0.653 0.653 
 
Table 3.3: Summary of the area per lipid in the CG simulations. The reference value is    0.65 +/- 
0.05, we can see that all simulations are within the desirable ranges of values.116  
The orientation of both proteins anchored to the membrane was consistent with the 
experiments.29,73,117 GCase was oriented with the loops at the entrance of the binding site 
facing the phospholipid membrane. As GluCer anchored in the membrane, it was 
anticipated that the active site will be facing the membrane. The orientation of Sap-C alone 
was very similar to that observed in the experimental studies of membrane interaction, 
explained in Chapter 2 (Figure 2.7). Furthermore, both GCase and Sap-C remained together 
during the course of the entire simulation run. This further enhanced our confidence in the 
selection of the GCase-Sap-C model for further studies. 
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Figure 3.4: Evolution of the system of GCase, Sap-C and GluCer (Simulation 3-CPX-GC). 
Snapshots taken at (i) 0 ns, (ii) 30 ns and (iii) 1200 ns. At 30 ns the membrane is not completely 
formed although the bilayer has taken shape. After approximately 100 ns the membrane is 
completely formed. The complex of the proteins and the substrate is well anchored till the end of 
the simulation (1200 ns). DPPC lipids have been coloured in mauve, GCase is been coloured in 
green, Sap-C in yellow and GluCer in magenta. 
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3.3.2. Atomistic Molecular Dynamics Simulations. 
3.3.2.1.Wild type Proteins 
3.3.2.1.1. General Analysis 
The self-assembled coarse-grained systems were re-converted into atomistic detail in order 
to study the conformational dynamics of the complex in lipid. Table 3.2. provides a list of 
atomistic simulations carried out. 
We started analysing the simulations of wild type GCase in complex with or without Sap-
C; namely simulations 1 (GCase-Ext), 2a (GCase-Hel and GluCer), 2b (GCase-Ext and 
GluCer), 3a (CPX-Hel) and 3b (CPX-Ext), and also Sap-C in simulation 4 (Sap-C). We 
analysed and compared them to understand how GCase behaved in different complexes 
and interacted with the different components. We then analysed the simulations of GCase 
mutants and compared them with each other and with the wild type in order to understand 
the structural implications of the mutations on the conformational dynamics of GCase. 
Conformational drift of a protein or complex was evaluated by measuring the Root-mean 
square deviation (RMSD) of Ca atoms from the initial structure. We have focussed on 
GCase in different simulations (and Sap-C in those that contain it) to assess its 
conformational stability.  
Overall, the structures are stable in simulations 2a (GCase-Hel and GluCer), 2b (GCase-
Ext and GluCer), 3a (CPX-Hel) and 3b (CPX-Ext), as assessed by RMSD values, shown 
in Figure 3.5. Equilibration was reached at approximately 250 ns in all the simulations 
except in 2b (GCase-Ext and GluCer) which does not stabilise until 700 ns, after a period 
of relaxation of the system. The overall RMSD value or equilibrium value for active GCase 
when it is simulated without Sap-C in Simulation 2a (GCase-Hel and GluCer) (3.8 Å, 4.1 
Å after reaching the equilibrium) is considerably higher than when it is simulated in 
complex with Sap-C in Simulation 3a (CPX-Hel)  (2.7 Å). The difference in RMSD values 
indicates that the active conformation of GCase is stabilised, when in complex with Sap-C 
in simulation 3a (CPX-Hel). When we examine inactive GCase, we observe that in 
simulation 2b (GCase-Ext and GluCer) the equilibrium is not reached until after 700 ns of 
simulation. When it is simulated in complex with Sap-C in Simulation 3b (CPX-Ext) the 
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equilibrium value (4.0 Å) was reached earlier in the simulation after approximately 250 ns. 
The structural changes in the conformations result in greater RMSD values of the extended 
conformation of GCase in presence of Sap-C, however in absence of Sap-C GCase shows 
less conformational stability. 
 
 
 
Figure 3.5: Ca-RMSD values of GCase, plotted as a function of time for simulations 2a, 2b, 3a 
and 3b.  
In order to better understand conformational flexibility, we measured the RMS Fluctuation 
for each residue (RMSF). This measure gives a detailed idea of the local flexibility. It is 
not surprising that the loops on the surface of the protein are more mobile than those within 
the core. It also indicates that there is not any important conformational drift within the 
core structure. Results are shown in figure 3.6. Loops at the entrance of the binding site do 
not show high fluctuation. Loop-1 (311-319) shows similar levels of fluctuation in 
Simulations 2a (GCase-Hel and GluCer), 3a (CPX-Hel) and 3b (CPX-Ext), between 1 and 
2 Å. In Simulation 2b it exhibits higher values of fluctuation. In simulation 2b, Loop-1 
extends to helix 7 adopting an even more extended form. Loop-2 (345-351) presents higher 
values of RMSF in Simulation 2a (GCase-Hel and GluCer) (3Å) and 3b (CPX-Ext) (2Å). 
In simulation 2a (GCase-Hel and GluCer) Loop-2 gets embedded, while in simulation 3b 
(CPX-Ext) it gets trapped under Sap-C which prevents the loop to insert into the membrane 
(Figure 3.15). Loop-3 (395-399) shows a higher fluctuation in Simulation 3b (CPX-Ext), 
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where it adopts an active form (Figure 3.15), with a peak of 2.2 Å for residue 395. Loop-4 
(237-248) peaks in simulation 2a (GCase-Hel and GluCer) and 3a (CPX-Hel) with values 
of 2 and 3 Å, respectively. Loop-5 does not fluctuate significantly throughout the 
simulations. Helix 7 which contains the important residue N370 does not show a high 
fluctuation throughout the simulations, although the value is slightly greater in Simulation 
3b (CPX-Ext).Those residues implied in the protein-protein binding (Y11-S12, R44-S45, 
Q440-D445, S464-S465 and Y487) also show a higher fluctuation throughout Simulation 
3b (CPX-Ext). 
The other peaks showing greater fluctuation in RMSF plot are mainly surface loops and 
parts of the protein. For instance, there is an increased fluctuation observed in fragment 
296-304, corresponding to helix 5 of the TIM-Barrel as it approaches to the membrane 
during the course of simulation 2a (GCase-Hel and GluCer) and 2b (GCase-Ext and 
GluCer). This fluctuation does not occur when GCase in complex with Sap-C. In 
simulation 2a (GCase-Hel and GluCer), the RMSF peaks at residue 270. This residue is 
positioned at the edge of helix 4 in the active form of GCase (helical) and interacts with 
the solvent, whereas in the inactive (extended) form it is connected to the 𝛽 −sheet 5 via 
hydrogen bonds, pointing towards the inside of the protein. During the simulation 2a 
(GCase-Hel and GluCer),  residue 270 goes from interacting with the solvent to making an 
interaction with 𝛽 -sheet 5, thereby generating a peak in the RMSF graph. During 
simulation 3a (CPX-Hel), the residue does not make any interactions and the fluctuation is 
only as a result of being a surface residue. In simulation 3b (CPX-Ext), the residue goes 
from interacting to non-interacting conformation towards the end of the simulation and in 
simulation 2b (GCase-Ext and GluCer) it maintains its interactions with the 𝛽 -sheet 5. 
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Figure 3.6: (a) Comparison of RMSF (GCase) as a function of each residue in simulations 2a, 2b, 
3a and 3b. Loops-1 to -5 at the entrance of the binding site have been highlighted in yellow and 
tagged with the label L1 to L5, helix 7 has been highlighted in blue and the protein-protein binding 
site, other than Loops 1 and 2 and helix 7, has been highlighted in magenta. The secondary 
structure of the protein can be found on the top of the graph, helices of the TIM barrel have been 
labelled. (b) RMSF values from simulation translated on the structure of GCase in simulation (i) 
2a (GCase-Hel and GluCer), (ii) 2b (GCase-Ext and GluCer),(iii) 3a (CPX-Hel) and (iv) 3b (CPX-
Ext)  
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Ca RMSD values of Sap-C were also measured when it was present (simulations 3a and 
3b) in the model. Sap-C is stable in all three simulations (3a (CPX-Hel), 3b (CPX-Ext) and 
4 (Sap-C)). The higher RMSD value was observed in simulation 3b (CPX-Ext)  (4.9 Å). 
Simulation in 3a (CPX-Hel) showed an RMSD value 3.8 Å. The lowest value was observed 
in Sap-C when it is simulated alone in simulation 4 (Sap-C) (3.4 Å). Equilibration was 
reached at approximately 200 ns in all the simulations. As shown in Figure 3.7, RMSD 
value of simulation 4 (Sap-C) undergoes a dramatic increase between 100 and 150 ns. 
During this time in the said simulation Sap-C anchors to the membrane and adopts a similar 
orientation and conformation to that observed in simulation 3a (CPX-Hel) and 3b (CPX-
Ext) and that mentioned in experimental studies (Figure 3.8). 
 
 
Figure 3.7: Ca-RMSD values of Sap-C plotted as a function of time for simulations 3a, 3b and 4. 
The vertical dashed line indicates the time at which the equilibration is reached. 
To understand Sap-C flexibility we calculated the RMSF values during different 
simulations. Sap-C is a small protein and much simpler in structure than GCase. RMSF 
values plotted in Figure 3.8, highlight that only the loops that connect helices show a high 
RMSF value (above 2 Å). 
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Figure 3.8:  Comparison of RMSF in the facilitator protein Sap-C as a function of each residue in 
simulations 3a (CPX-Hel), 3b (CPX-Ext) and 4 (Sap-C). Loops joining the helices together have 
been highlighted in yellow and tagged with the label L1-2, L2-3 to L4-5 referring the helices that 
join. The secondary structure of the protein can be found on the top of the graph and the helices of 
the protein have been labelled. 
 
Figure 3.9: Snapshots of Sap-C in simulation 4, from 50 to 250 ns, period at which the RMSD value 
of the protein increases dramatically. The protein has been coloured gradually from red (50 ns) to 
white (250 ns). Helices 1 (C’-terminus) and 5 (N’-terminus) both get embedded in the membrane. 
Nitrogen and Phosphate atoms of the phospholipids have been depicted as spheres in blue and 
orange respectively. 
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3.3.2.1.2. Membrane Anchoring 
It would be useful to count how many and what residues of the protein interact with the 
membrane as the simulation progresses. We have considered those residues in GCase that 
lie 4.5 Å away from the membrane to directly interact with it. Table 3.4 summarises these 
residues that interact with the membrane at 1000 ns. Membrane anchoring gets stronger 
during the initial equilibration phase, in all the cases. The measure of distance between the 
centres of mass of the protein and the lipid bilayer as a function of time shows the closeness 
of the protein to the bilayer. We can observe that the distances between the centres of mass 
become smaller as the equilibration progresses and remains stable thereafter (Figure 3.5). 
In simulations of the complex (3a (CPX-Hel) and 3b (CPX-Ext)), the equilibrium distance 
to the membrane is greater as Sap-C is positioned between GCase and the membrane. It is 
also worth mentioning that GCase in simulation 3a (CPX-Hel) needs more time to stabilise 
in the membrane. 
 
SIMULATION RESIDUES INTERACTING WITH MEMBRANE 
2A- GCASE- GLUCER G62, T63, G64, P139, T187, G189, G193, K194, G202, D203, 
G243, Y244, P245, F246, G250, V294, V295, L296, T297, 
P299, F316, P319, A320, K321, G325, H328, R329, E349, 
Q350, S351, V394, Q440, K441, N442, S464, S465 
2B- GCASE- GLUCER G10, Y11, G64, L65, L66, Y135, P139, G189, A190, G193, 
K194, N200, G202, P253, A292, K293, E300, L314, P319, 
A320, K321, A322, Q350, S439, Q440, K441, S465, K466 
3A- CPX (HEL) K131, P139, D140, D141, A190, V191, G199, N200, P201, 
P236, L241, S242, P245, P299, T323, W348, G390, R395, 
N396 
3B-CPX (EXT) K7, S8, G10, Y11, D127, I130, K131, T132, N188, G189, A190, 
G193, K194 G199, N200, S237, S242, G243, F316, L317, 
N350, G389, P391-N396, D405-K408 
Table 3.4: Residues directly interacting with the membrane at 1000 ns. Some differences between 
active forms of the enzyme and inactive form are observable, as well as how the presence of Sap-
C influences the membrane binding.	
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Figure 3.10: Distance between the centre of mass of GCase and the centre of mass of the lipid 
membrane. 
3.3.2.1.3. Electrostatic surfaces 
The analysis of the electrostatic surfaces of the proteins provides a good understanding of 
the conformational evolution of the system. Active and inactive GCase show overall 
similar electrostatic features. At 0 ns, Domain I is positively charged in the regions that 
face the lipid membrane and less positive away from the bilayer. Domain II, like Domain 
I, shows more positive character in the proximities of the lipid membrane, although the 
most positively charged area is a cluster of side chains positioned towards the end of helix 
7 and 6 of domain III, and includes positively charged residues: K293 (Helix 5), K321, 
H328, R329 and H374. Domain III is noticeably negatively charged in the active site, the 
loops around the binding site are neutral although certain residues provide some 
electropositivity. The TIM barrel is more positive on the face opposite to the membrane. 
However, there are some features specific to each simulation. The electrostatic surfaces 
evolve with the system dynamics. Figure 3.11 and 3.12 shows the evolution of the 
electrostatic surface of GCase in different simulations, depicted at 0 and 1000 ns of 
simulation time. The activation or inactivation process that the protein experiences are 
reflected in the electrostatic surfaces. Furthermore, some of the RMSF characteristics that 
have been mentioned above are also observed by analysing the electrostatics surfaces. 
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Figure 3.11: The evolution of the electrostatic surface in simulation 2a (GCase-Hel and GluCer) 
and 2b (GCase-Ext and GluCer)  at 0 and 1000 ns of simulation time. Electrostatic surface of 
GCase in simulation 2a at (a) 0 ns and (b) 1000 ns. As Loop-1 in simulation 2 loses its helicity, it 
closes the active site; Loop-4 also progress towards the active site.. Electrostatic surface of GCase 
in simulation 2b at (c) 0 ns and (d) 1000 ns. It is important to note that Loop-1 extends towards 
helix 7. The position of Helix 7 has also been highlighted to illustrate the electropositive cluster. 
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Figure 3.12: The evolution of the electrostatic surface in simulation 3a (CPX-Hel) and 3b (CPX-
Ext). Electrostatic surface of GCase in simulation 3a at (a) 0 ns and (b) 1000 ns. Loop-1 does not 
change conformation in Simulation 3a as it does in Simulation 3a; Loop-4 progresses towards the 
active site in simulation 2 although it does not occlude the active site significantly. Electrostatic 
surface of GCase in simulation 3b at (c) 0 ns and (d) 1000 ns. It is worth noting that Loop-1 and 
Loop-3 change conformation that leads to widening of the active site. The position of Helix 7 has 
also been highlighted to illustrate the electropositive cluster. 
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3.3.2.1.4. Loop Dynamics  
Analysis of the dynamics of the loops at the entrance of the binding site shed light on the 
activation mechanism of the enzyme. In simulation 2a (GCase-Hel and GluCer) Loop-1 
partially loses its helical structure as the simulation progresses. However, when Sap-C is 
present in simulation 3a (CPX-Hel), the hydrogen bond between D315 of GCase and K33 
of Sap-C is maintained over the entire simulation (Fig. 3.13). This hydrogen bond stabilizes 
the helical conformation of Loop-1.  In simulation 3b (CPX-Ext), the side chain of K33 
interacts with the backbone atoms of residue L314 and Y373. Although in simulation 3b 
(CPX-Ext) the helix formation is not complete, there are some observable differences with 
conformations seen in simulation 2b (when Sap-C is not present) as illustrated in Figure 
3.14.		
We also observe differences in the evolution of Loop-2 and Loop-3 in the presence and 
absence of Sap-C. In active state simulation (3a), the side chain of W348 in Loop-2 is 
oriented towards the outside of the binding site, tucked in a hydrophobic pocket formed by 
Sap-C. In simulation 3b (CPX-Ext), the side chain of W348 is also trapped under Sap-C. 
However, in simulation 2b (GCase-Ext and GluCer), the side chain of W348 partially 
obstructs the entrance of the binding site due to its bulkiness. In simulation 2a (GCase-Hel 
and GluCer) W348 is embedded in the membrane. 
In the inactive state of the enzyme, residue R395 and catalytic residue E340 form a stable 
hydrogen bond. This hydrogen bond blocks the entrance of the binding site and maintains 
the catalytic site in the inactive state. This interaction is not observed in simulation 3b 
(CPX-Ext). During simulation 3b, R395 orients towards the outside of the activation site, 
ending up in a very similar position as it is in the active state. The interaction between the 
catalytic residue E340 and residue R395 gets formed during the equilibration time. In the 
active state, Loop-1 adopts a characteristic helical conformation. 	
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Figure 3.13: A hydrogen bond between D315 (GCase) and K33 (Sap-C) maintains the helical 
conformation of Loop-1. Snapshots of conformations extracted from simulation 3a at (a) 0ns, (b) 
500ns and (c) 1000ns are illustrated. (d) Minimum distance between K33 and D315 in simulation 
3a. GCase has been coloured blue, while Sap-C is coloured green. A comparison of conformations 
adopted by Loop-1 in simulation 2a (GCase in orange) has also been made at equivalent time and 
superimpositioned on that of 3a. 
 
 
Figure 3.14: Comparison of conformations adopted by Loop-1 in simulations 2b (red) and 3b 
(yellow) at (a) 0, (b) 500 and (c) 1000 ns. Loop-1 in simulation 2b extends towards helix 7. The 
interaction of residue K33 of Sap-C with the neighbouring residues of D315 influences Loop-1 to 
adopting a helical conformation. 
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Figure 3.15: Conformation of the loops at the entrance of the binding site: (a and b) Loop-
2 and (c) Loop-3 in simulations 2a (orange), 2b (red), 3a (blue) and 3b (yellow) at 1000 
ns. (b) Snapshot of GCase-Sap-C (green) complex at 1000 ns in simulation 3b. Sap-C 
stabilizes the active form of the Loop-2, where residue W348 of GCase lies in a 
hydrophobic pocket formed in Sap-C. (c) Orientation of side chains of R395-E340 in 
different simulations at 1000ns. (d) Distance between side chains of residues R395 and 
E340 of GCase in simulation 2a, 2b, 3a and 3b. 
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3.3.2.1.5. Interactions in the binding site 
Some of the interactions occurring in the active site are of paramount importance to 
understand the activation process of the enzyme GCase, as well as the implications of some 
mutations of the protein. Since the interactions made within the binding site have been 
thoroughly studied and reported in the literature27, we have not focused on them in this 
thesis. However, we do need to include some remarks regarding the differences observed 
at the active sites in different simulations.  
There is a high presence of aromatic and hydrophobic residues in the loops at the entrance 
of the binding site. Firstly, these loops provide an anchor to the phospholipid membrane 
where hydrophobic effect is the driving force of the interaction.118 119 120 121 Secondly, 
aromatic residues are habitually found in the binding sites of glucose and polysaccharides 
specific proteins. Aromatic residues, specially Tyrosine, Phenylalanine and Tryptophan, 
have been reported to provide a geometrical complementary surface to the sugar ring of 
the glucose, the interaction being energetically very favourable.122 The mentioned residues 
help in the molecular recognition of the substrate and provide a platform to help it to move 
through the binding site.  
We have found some differences in the evolution of the active sites in all four simulations. 
In general, the substrate, as it is normal in long MD simulations, moved considerably 
during the simulation time. As expected, in simulations that start from the active 
conformation, namely 2a (GCase-Hel and GluCer) and 3a (CPX-Hel), the substrate lasted 
more time in the docked position. This is probably because in the inactive (Apo) 
conformation the docking is not optimal since the enzyme is not supposed to interact with 
the ligand in that conformation. 
Along with the catalytic residues E235 and E340, Y313 (Loop-1) plays an important role 
in guiding the substrate to the catalytic site and stabilising it inside the pocket. This residue 
is observed to display syncretic behaviour with GluCer in all four simulations (Figure 3.16 
to 3.19). Y244 (Loop-4) is another residue that interacts with and prevents the substrate to 
slip out of the binding site at various times in different simulations.  
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The presence of Sap-C directly affects the interactions of GluCer in the binding site. It 
influences a change in the conformation inside the binding site. In simulation 2b (GCase-
Ext and GluCer), the interaction between residue E340 and R395 completely blocks the 
active site (Figure 3.15). GluCer remains positioned over the blocked binding site by 
making interactions with Y244 (Loop 4) for a while, but that is finally broken and the 
substrate slips completely out of the binding site.  
In simulation 2a (GCase-Hel and GluCer), GluCer goes beyond interacting distance of the 
catalytic residues (E235 and E340) after approximately 200 ns of simulation, but it remains 
in the pocket. GluCer establishes interactions with Y313 and Y244. The interaction with 
Y313 occurs since the beginning of the simulation. Towards the middle of the simulation 
GluCer interacts with the hydrophobic residues of Loop-4: A238, G239, L241 and L240, 
and also residues of Loop-5 L283 and L286. GluCer remains between the two loops until 
the end of the simulation. 
In simulation 3a (CPX-Hel), GluCer partially slips out of the active site in the first 150 ns 
of simulation. The substrate is prevented to completely leave the active site by the 
interactions made with the aromatic residues W393 (Loop-3) and Y244 (Loop-4), and 
towards the end of the simulation with the residue F347 (Loop-2) and F316 (Loop-1). 
In simulation 3b (CPX-Ext), GluCer leaves the catalytic site in the first 50 ns of simulation. 
After that, the substrate keeps interacting with residues W393 (Loop-3) and Y244 (Loop-
4), and later with residues W393, F397 (Loop-3), Y313 and F316 (Loop-1) until the end 
of the simulation. Unlike in the inactive form of GCase simulated without Sap-C, the 
substrate in simulation 3b does not leave the pocket completely. 
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Figure 3.16: Interactions occurring in the binding site in simulation 2a (GCase-Hel and GluCer) 
at (a) 0 ns, (b) 250, (c) 750 and (d) 1000 ns. Towards the end of the simulation the substrate is only 
attached to Loop-4 of GCase. GluCer has been depicted in green, GCase in white with the 
interacting residues in orange and catalytic residues (E235 and E340) in cyan. 
 
Figure 3.17: Interactions occurring in the binding site in simulation 2b (GCase-Ext and GluCer) 
at (a) 0 ns, (b) 250, (c) 750 and (d) 1000 ns. GluCer abandons the binding pocket at the end of the 
simulation. GluCer has been depicted in green, GCase in white with the interacting residues in red 
and catalytic residues (E235 and E340) in cyan. 
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Figure 3.18: Interactions occurring in the binding site in simulation 3a (CPX-Hel) at (a) 0 ns, (b) 
250, (c) 750 and (d) 1000 ns. The substrate makes stable interactions with aromatic residues during 
the simulation. F347 seems to have an important role maintaining GluCer inside the binding site. 
GluCer has been depicted in green, GCase in white with the interacting residues in blue and 
catalytic residues (E235 and E340) in cyan. 
 
Figure 3.19: Interactions occurring in the binding site in simulation 3b (CPX-Ext) at (a) 0 ns, (b) 
250, (c) 750 and (d) 1000 ns. Similar to the observation in simulation 3a, the substrate makes stable 
interactions with aromatic residues during the simulations. GluCer has been depicted in green, 
GCase in white with the interacting residues in yellow and catalytic residues (E235 and E340) in 
cyan.  
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3.3.2.1.6. Protein- protein interactions 
There are several Protein-Protein interactions (PPi) that stabilize the GCase-Sap-C 
complex. The protein-protein interactions occurring in simulation 3a (CPX-Hel) are shown 
in Figures 3.20 and 3.21 and are summarised in Table 3.5. The protein-protein interface 
lies between Domain II of GCase and Loop-1 and -2 at the entrance of the binding site, just 
below helix-7 of the Tim-Barrel. In simulation 3a (CPX-Hel), residue K33 of Sap-C forms 
stable hydrogen bonds with residue D315 of Loop-1. In Loop-2, we observed one steady 
hydrogen bond interaction between residues S43 (Sap-C) and W348 (GCase). In helix-7 of 
the Tim-Barrel (that contains the clinically important residue N370), the interactions 
between GCase and its facilitator protein are also consistent, as between the residues D29 
(Sap-C) and H365 (GCase). Finally, interactions occurring in Domain II of GCase includes 
those between residue D51 (Sap-C) and R44 and Y487, between S59 (Sap-C) and residues 
S464 of GCase, between residues S59 (Sap-C) and S464 (GCase) and between residues 
K25 of Sap-C and N442, D445, D443 (backbone) and L444 (backbone) of GCase. 
 
 
Figure 3.20: Protein-protein interactions in simulation 3a (CPX-Hel) in (a) Loop-1 and helix 7, 
(b) Loop-2, (c and d) Domain II.. Sap-C has been coloured in green and GCase has been coloured 
blue. Important residue N370 has been represented with spheres and coloured in cyan. 
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Figure 3.21: Interactions at the protein-protein interface observed in simulation 3a. 
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In simulation 3b (CPX-Ext), residue T23 and K33 of Sap-C forms steady hydrogen bonds 
with Loop-1 including residue K321 and the backbone of residue L314 respectively. In 
Loop-2, we observed two very stable hydrogen bond interactions between residues S43 
(Sap-C) and E349 (GCase) and between residues S36 (Sap-C) and K346. In helix-7 of the 
Tim-Barrel, the interactions between GCase and the facilitator protein are also consistent, 
including that between D32 (Sap-C) and H365 (GCase), between D29 and Y373 (Sap-C 
and GCase respectively) and between K33 (Sap-C) and Y373. Finally, interactions 
occurring in Domain II of GCase include those between residues Q47 (Sap-C) and S45 
(GCase), between D55 (Sap-C) and R44 and S465, between S55 (Sap-C) and residues S465 
and S464 of GCase, and between residues K25 of Sap-C and D443, L444 and D445 of 
GCase. The protein-protein interactions occurring in simulation 3b (CPX-Ext) are shown 
in  the figures 3.22 and 3.23 and summarised in Table 3.5.   
 
 
 
Figure 3.22: Protein-protein interactions in simulation 3b (CPX-Ext) in (a) Loop-1, (b) Helix 7 
and (c and d) Domain II. Sap-C has been coloured in green and GCase has been coloured yellow. 
Important residue N370 has been represented with spheres and coloured in cyan. 
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Figure 3.23: Interactions at the protein-protein interface observed in simulation 3b. 
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Sap-C  3a- CPX (Hel) 3b-CPX (Ext) 
T23 - K321 
K25 D445 
D443(bb) 
N442 
L444(bb) 
D445 
D443 
L444 
E26 - A320 
K321 
D29 H365 Y373 
D32 - H365 
K33 D315 Y373 
L314 
S36 - K346 
S43 W348 E349 
Q47 D358 S45 
D51 Y487 
D51(bb)-Y487 
R44 
R44 (from 250 ns) 
S465 
Y487 (until 300 ns) 
S55 Y487 (from 450 ns) S464 
S465 
S59 D443 (from 450 ns) 
S464 (until 400 ns) 
S465 (until 450 ns) 
- 
L62(bb) K441(bb) K441 
E63 Q440 
E63(bb)-K441 
E63(bb)-K441 
 
Table 3.5: Summary of protein-protein interaction in simulations 3a and 3b. The abbreviation bb 
stands for ‘backbone’. 
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3.3.2.2.Mutant proteins 
AT-MD simulations were also performed for two of the most clinically relevant mutants 
in GCase, namely: N370S and L444P. Both mutant proteins were simulated along with the 
facilitator protein Sap-C in a membrane environment, and both conformations of GCase 
were used for each mutant. A total of four simulations were conducted in order to 
understand the structural implication of these mutations. 
 
3.3.2.2.1. General analysis 
To start the analysis, C𝛼- RMSD of GCase was calculated in all four simulations and 
compared to the wild type. First, simulations with active conformation (helical) of GCase 
were analysed, namely 3a (CPX-Hel), 5a (CPX-Hel(N370S)) and 6a (CPX-Hel(L444P)). 
The RMSD results show an overall conformational stability of the enzyme in the three 
simulations (Fig. 3.24). The equilibration time in the wild type simulation (3a (CPX-Hel)) 
was shorter than in its homologue mutants (5a (CPX-Hel(N370S) and 6a (CPX-
Hel(L444P)), approximately 100 ns versus 250 ns in the mutants. In simulation 3a (CPX-
Hel), the average of the RMSD value from the end of the equilibration is lower (2.4 Å) 
than in simulation 5a (CPX-Hel(N370S) (3.1 Å) and 6a (CPX-Hel(L444P)) (3.4 Å), 
indicating a higher conformational stability of the wild type.  
Secondly, those simulations containing the inactive (extended form) conformation of 
GCase were analysed, namely 3b (CPX-Ext), 5b (CPX-Ext(N370S)) and 6b (CPX-
Ext(L444P)). Once again, the results reveal an overall conformational stability (Fig. 3.25). 
In simulation 6b (CPX-Ext(L444P)), however, the value of RMSD fluctuates more than in 
the others. The equilibration time in simulation 3b (CPX-Ext), the wild type, is shorter 
(~.100 ns) than in the mutants (~ 250 ns). In simulation 3b (CPX-Ext), unlike its active 
counterpart, the average RMSD value from the end of the equilibration is slightly higher 
(3.8 Å) than in simulation 5b (3.6 Å) and similar to the average in 6a (3.8 Å), indicating a 
high conformational flexibility in all three simulations. 
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Figure 3.24: Ca-RMSD values of GCase, plotted as a function of time for simulations 3a, 5a and 
6a.  
 
 
Figure 3.25: Ca-RMSD values of GCase, plotted as a function of time for simulations 3b, 5b and 
6b.  
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The RMSF values were also analysed for all four simulations. The simulations of the active 
form of the enzyme, 3a (CPX-Hel), 5a (CPX-Hel(N370S)) and 6a (CPX-Hel(L444P)) do 
not exhibit high fluctuation (Figure 3.26). There are only three peaks above 2 Å. Once 
again, the highest peaks in RMSF values correspond to surface loops, thus indicating a 
good core stability of the enzyme. Loop-1 does not show high fluctuation in any of the 
simulations, although it is higher in the mutants than in the wild type (2 Å in 5a, 2.2 Å in 
6a, and 1.5 Å in 3a). Loop-2 and Loop-3, do not exhibit high RMSF values in any of the 
simulations. Loop-4 does not present high fluctuation in any simulation except simulation 
3a with an RMSF value of 3 Å. Apart from the mobility of the loops at the entrance of the 
binding site, helix 6 of the TIM- Barrel (residue 321 to 330) exhibit high RMSF value (7 
Å) in simulation 6a, this is because helix 6 deforms towards helix 7,  due to the poor 
docking of the two proteins, losing its helicity. It is also worth noting the high fluctuation 
of residue N270 in the three simulations. This is primarily due to 270 being a surface 
residue, which is free to interact with the solvent. Helix 7, which contains the important 
residue N370, does not show high fluctuation throughout these simulations. On the other 
hand, those residues implied in the protein-protein binding (Y11-S12, R44-S45, Q440-
D445, S464-S465 and Y487) do not show a high fluctuation throughout any of these 
simulations. 
The RMSF values for the extended form of GCase in simulations 3b (CPX-Ext), 5b (CPX-
Ext(N370S)) and 6b (CPX-Ext(L444P)) were also analysed (Figure 3.27). The core of the 
enzyme is stable in all three simulations, while the highest peaks correspond to surface 
loops of the protein. Loop-1 does not show high fluctuation in any of the simulations. Loop-
2 exhibit a higher value in simulation 3b with a value of 2.2 Å whereas the mutants showed 
values lower than 2 Å. Loop-3 again shows a higher value in simulation 3b (2.4 Å) than in 
its mutant counterparts (1 Å approx.). Loop-4 shows a peak of 2.8 Å in simulation 5b, 
whereas in the simulation 3b and 6b, it has an RMSF value of 1.9 Å and 1.8 Å respectively. 
RMSF values of Loop-5 also vary: in simulation 6b it has value of 3 Å, whereas in 
simulation 3b and 5b, that values are below 2 Å. Helix 5 (residue 269 to 304) and Helix 6 
(residue 321 to 330) of the TIM- Barrel display high fluctuation in the two mutant 
simulations 5b and 6b. Furthermore, an increase in fluctuation is observed for residue 270 
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in all three simulations. Residue 270 goes from interacting with 𝛽-sheet 5 to that which 
interacts with the solvent. As in simulations 5a and 6a, helix 7 does not show a high 
fluctuation throughout simulations 5b and 6b. Those residues implied in the protein-protein 
binding (Y11-S12, R44-S45, Q440-D445, S464-S465 and Y487) also show a higher 
fluctuation throughout simulation 3b (CPX-Ext) and 6b (CPX-Ext(L444P)). 
 
 
 
 
Figure 3.26: (a) Comparison of RMSF (GCase) as a function of each residue in simulations 3a 
(CPX-Hel), 5a (CPX-Hel(N370S)), and 6a (CPX-Hel(L444P)). Loops-1 to -5 at the entrance of the 
binding site have been highlighted in yellow and tagged with the label L1 to L5, helix 7 has been 
highlighted in blue and the protein-protein binding site, other than Loops 1 and 2 and helix 7, has 
been highlighted in magenta. The secondary structure of the protein can be found on the top of the 
graph, helices of the TIM barrel have been labelled. (b) RMSF values from simulation (i) 3a (CPX-
Hel), (ii) 5a (CPX-Hel(N370S)) and (iii) 6a (CPX-Hel(L444P)). 
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Figure 3.27: (a) Comparison of RMSF (GCase) as a function of each residue in simulations 3b 
(CPX-Ext), 5b (CPX- Ext (N370S)), and 6b (CPX- Ext (L444P)). Loops-1 to -5 at the entrance of 
the binding site have been highlighted in yellow and tagged with the label L1 to L5, helix 7 has 
been highlighted in blue and the protein-protein binding site, other than Loops 1 and 2 and helix 
7, has been highlighted in magenta. The secondary structure of the protein can be found on the top 
of the graph, helices of the TIM barrel have been labelled. (b) RMSF values from simulation (i) 3b 
(CPX- Ext), (ii) 5b (CPX- Ext (N370S)) and (iii) 6b (CPX- Ext (L444P)). 
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3.3.2.2.2. Electrostatic surfaces 
The electrostatic surfaces of the mutants were analysed throughout the course of the 
simulations as a way to evaluate the overall dynamics of the mutant proteins. Figures 3.28 
and 3.29 show the evolution of the electrostatic surfaces in simulation 5a (CPX-
Hel(N370S)) and 6a (CPX-Hel(L444P)) and in simulation 5b (CPX-Ext(N370S)) and 6b 
(CPX-Ext(L444P)), respectively. 
 
 
Figure 3.28: The evolution of the electrostatic surface in both simulation 5a (CPX-Hel(N370S)) 
and 6a (CPX-Hel(L444P)) is depicted at 0 and 1000 ns of the simulation time. Electrostatic surface 
of GCase in simulation 5a at (a) 0 ns and  (b) 1000 ns. Electrostatic surface of GCase in simulation 
6a at (c) 0 ns and (d) 1000 ns. Loop-1, Loop-2 and Helix 7  have been tagged. 
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Figure 3.29: The evolution of the electrostatic surface in both simulation 5b (CPX-Ext(N370S)) 
and 6b (CPX-Ext(L444P)) is depicted at 0 and 1000 ns of the simulation time. Electrostatic surface 
of GCase in simulation 5b at (a) 0 ns and  (b) 1000 ns. Electrostatic surface of GCase in simulation 
6b at (c) 0 ns and  (c) 1000 ns.  Loop-1, Loop-2 and Helix 7 have been tagged. 
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3.3.2.2.3. Loops Dynamics 
The mutant protein-Sap-C complexes are unstable. This instability affects the dynamic 
evolution of GCase over the course of the simulation. 
The simulations of the mutated protein confirm that loop dynamics is affected by the 
mutations. In the first 300 ns of simulation 5a (CPX-Hel(N370S)), the helical conformation 
of Loop-1 is lost in the mutant. This is consistent with when GCase is simulated alone 
(simulation 2a (GCase-Hel and GluCer)). The helicity of Loop-1 is however partly 
recovered when interactions between K33 (Sap-C) and the side chain of D315 (GCase) is 
made during the second half of the simulation (Fig. 3.30). In simulation 6a (CPX-
Hel(L444P)), Loop-1 does not lose it helical form during the simulation although the helix 
gets deformed and moves towards the Loop-2. The helicity is maintained because the 
formation of a hydrogen bond between D315 and K33 of Sap-C and  due to additional 
interactions with H365 an S366 in helix 7. In the mutant simulations, the bad coupling 
between the two proteins leaves the Loop-2 free, unlike in the wild type simulations where 
Loop-2 remained tucked under Sap-C. The evolution of Loop-3 is also different in mutants: 
while in the wild type, residue R395 is oriented towards the outside of the active site, in 
simulation 5a (CPX-Hel(N370S)) it is oriented towards the inside forming a hydrogen bond 
with residue S350 of Loop-2. In simulation 6a (CPX-Hel(L444P)), side chain of residue 
R395 is still pointing towards the exterior of the binging pocket. 
In the simulations of the extended form (inactive) of GCase, the evolution of the loops in 
the mutants and the wild type highlights some important differences (Fig. 3.31). In 
simulations 5b (CPX-Ext(N370S)) and 6b (CPX-Ext(L444P)), Loop-1 extends towards 
helix 7. Similar to the helical conformation in simulation 5b and 6b, residue W348 does 
not remain consistently tucked under Sap-C as it does in simulation 3b, the wild type. In 
simulations 5b and 6b Loop-3 adopts a closed conformation with residue R395 interacting 
with the catalytic residue E340. Such an interaction completely obstructs the binding site 
similar to that observed  in simulation 2b (GCase-Ext and GluCer). 
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Figure 3.30: Dynamic evolution of the loops at the entrance of the binding site in the mutant 
simulations 3a (CPX-Hel), 5a (CPX-Hel(N370S)), and 6a (CPX-Hel(L444P)). Snapshot taken at 
1000 ns of simulation time; GCase has been depicted in different colours depending on the 
simulation: 3a in blue, 5a in hot pink and 6a in cyan and represented as a cartoon, Sap-C has been 
coloured in green and represented as a surface. (a) Loop-1, (b-d) Loop-2, (e) Loop-3 and (f) 
distance between residues R395 and S345 in simulation 6a. Loop-1 maintains the helical 
conformation due to the influence of Sap-C. Further, due to the instability of the protein-protein 
binding, W348 (Loop-2) does not remain inserted in the hydrophobic pocket in the mutants. Finally, 
Loop-3 closes towards the binding site in simulation 6a. 
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Figure 3.31: Dynamic evolution of the loops at the entrance of the active site in simulations 3b 
(CPX-Ext), 5b (CPX- Ext (N370S)), and 6b (CPX- Ext (L444P)).  Snapshot taken at 1000 ns of 
simulation time; GCase has been coloured in yellow (3b), dark grey (5b) and purple (6b), Sap-C 
has been coloured in Green and GCase has been depicted as a cartoon and Sap-C as a surface. (a) 
Loop-1, (b-d) Loop-2, (e) Loop-3 and (f) distance between residues R395 and catalytic residue 
E340 in simulation 6b. Loop-1 extends towards helix-7 in the mutant. Also, the poor binding 
between the two proteins prevents residue W348 from occupying the hydrophobic pocket in Sap-C. 
Furthermore, Loop-3 adopts a closed conformation in the mutants.  
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3.3.2.2.4. Interactions in the binding site. 
Mutations in GCase directly affect the dynamics of the loops and hence the interaction 
occurring in the binding site. Whereas in the wild type complexes 4a (CPX-Hel) and 4b 
(CPX-Ext) the substrate remains inside the pocket during the whole simulation time, in 
their mutant counterparts the substrate leaves the binding pocket along the simulation. We 
next summarise the most important interactions taking place in the binding site of the four 
mutants.  
In simulation 5a (CPX-Hel(N370S)), GluCer slips out of the catalytic site in the first 50 ns 
of simulation, but it remains inside the pocket thanks to the interaction with residue Y244 
in Loop-4 and residue N396 in Loop-3, as it can be observed in Figure 3.32. Towards the 
ends of the simulation GluCer also interacts with residue S345 in Loop-2. 
In simulation 5b (CPX-Ext(N370S)), the substrate goes completely out of the binding 
pocket after about 150 ns of simulation. From this point only the acyl tails of the ligand, 
and momentarily the head, are in contact with the loops of the binding site including some 
of the residues of Loop-4 like L241 and L240, these interactions are shown in Figure 3.32. 
During the first 100 ns of simulation 6a (CPX-Hel(L444P)), GluCer leaves the catalytic 
site but still remains inside the pocket by interacting with some residues of Loop-2 (F347), 
Loop-3 (V394, R395 and N396) and Loop-4 (F246) (Fig. 3.33). All these interactions are 
finally disrupted and the substrate slips completely out of the binding site after 750 ns of 
the simulation. 
Finally, in simulation 6b (CPX-Ext(L444P)) the substrate also abandons the binding 
pocket. After 400 ns of simulation, GluCer does not have any contact with the residues of 
the enzyme (Fig. 3.33). Before leaving the active site, the ligand establishes connections 
with F347 (Loop-2), F397 (Loop-3) and Y244 (Loop-4). Interactions between residues 
R395 and E340 occlude the entrance of the binding pocket and thereby making it 
impossible for the substrate to remain inside it. 
It is important to note that in all the mutant simulations, except in 5a (CPX-Hel(N370S)), 
GluCer finishes the simulation outside the binding pocket. This occurs in part because the 
interaction R395-E340 partly occludes the pocket making impossible for the substrate 
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come back to the binding site. We have observed this interaction in simulation 2b (GCase-
Ext and GluCer). 
 
 
Figure 3.32: Residues interacting with GluCer in simulation (a) 5a (CPX-Hel(N370S)) and (b) 5b 
(CPX-Ext(N370S)) at 500 ns. GluCer has been represented in green sticks and GCase in white with 
interacting residues in pink (5a) and grey (5b). Sap-c has been coloured in pale green. At 500 ns, 
only few interactions are observed in the binding site of the mutants.  
 
 
 
Figure 3.33: Residues interacting with GluCer in simulation (a) 6a (CPX-Hel(L444P)) and (b) 6b 
(CPX-Ext(L444P)) at 500 ns. GluCer has been represented in green sticks and GCase in white with 
interacting residues in cyan (6a). Sap-C has been coloured in pale green. In simulation 6b GluCer 
was completely outside of the binding pocket at 500 ns. At 500 ns, only few interactions are 
observed in the binding site of the mutant in Simulation 5b, whereas in Simulation 6a GluCer has 
abandoned the binding site at this time.  
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3.3.2.2.5. Protein- protein interactions 
The protein-protein interactions are also affected in mutants. Many of the interactions 
produced in the wild types are found disrupted in the mutants. In simulations 5a (CPX-
Hel(N370S)) and 5b (CPX-Ext(N370S)), where residue N370 has been mutated to Serine, 
the differences are notable (Fig. 3.34). In simulation 3a (CPX-Hel), the interaction between 
the residue H365 in helix 7 and residue D29 of Sap-C is consistent and stable during the 
simulation time, whereas it is absent in the mutant. In simulation 5a (CPX-Hel(N370S)), 
the interaction between residue D315 of GCase and K33 of Sap-C starts from 400 ns and 
partially recovers Loop-1 helicity. Interactions between residue K25 of Sap-C and residue 
N442 and D443 in the proximities of L444 are disrupted. However, the interactions 
between K25 and L444 and D445 are maintained. Some other protein-protein interactions 
are also broken, such as that between residue W348 and S43 (Sap-C) or between residues 
Q440 and E63 (Sap-C) (Fig. 3.36).  
In simulation 5b (CPX-Ext(N370S), the docking between the proteins is poor. After 
approximately 400 ns of the simulation, Sap-C detaches almost completely from the 
mutated GCase. At this point, Sap-C is positioned near a completely deformed Loop-1 
between residue K321 near Loop-1 and residues D29 and E26. Towards the end of the 
simulation, new interactions are formed between the mutant GCase and Sap-C, however 
not involving helix 7 (containing residue 370), for example, new interactions are formed 
between residue D51 of Sap-C and R44, Y487 or S465 of mutant GCase (N370S). Loop-2 
is completely free. Interactions between K25 and L444 and surrounding residues are 
completely disrupted in this mutant simulation. Additional interactions are made between 
D29 of Sap-C and Y373 in the proximities of N370. This interaction is observed and is 
very stable in the corresponding wild type (Fig. 3.37).  
In simulation 6a (CPX-Hel(L444P)) and 6b (CPX-Ext(L444P)), where L444 has been 
mutated to Proline the differences are also pronounced (Fig. 4.35). In simulation 6a (CPX-
Hel(L444P)), interactions between residues K25 and P444 and D445 are disrupted from 
600 ns onwards, although interaction with residue D443 is maintained from time 500 ns 
onwards. Interactions of Sap-C with Loop-1 of GCase are almost non-existent towards the 
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end of the simulation. Some interactions between Sap-C and Domain I and II of GCase are 
stable from 500 ns. For example, the interactions occurring between residue D51 of Sap-C 
and S12 and R44 of GCase (Fig. 3.38). 
Finally, in simulation 6b (CPX-Ext(L444P)), interactions between residue K25 and 
residues P444 and other surrounding residues as D445 and D443 are completely lost. The 
disruption of those interactions makes Sap-C partially detached and move towards the 
upper part of helix 7 near Domain I. Interactions with Loop 1 are again almost non-existent. 
Some stable interactions are those between the residues S43 (Sap-C) and Q350 (GCase) 
and between residues D51 (Sap-C) and R353 or W357 (backbone) of GCase (Fig. 3.39). 
 
Figure 3.34: Protein- protein interactions in simulation (a and c) 5a (CPX-Hel(N370S)) and (b 
and d) 5b (CPX-Ext(N370S)) are presented. Snapshot taken at 1000 ns of the simulation time. (a) 
General view of the complex GCase (white) and Sap-C (green), loops at the entrance of the binding 
site have been highlighted in pink (5a) and grey (5b) and been correspondingly labelled, mutated 
residue N370S has been coloured in cyan. (c and d) Detailed view of the protein binding site in 
simulation (c) 5a (CPX-Hel(N370S)) and (d) 5b (CPX-Ext(N370S)). GCase has been depicted in 
white and Sap-C in green. Interacting residues of GCase have been coloured in pink in 5a and dark 
grey in 5b. Mutated residue N370S has been coloured in cyan. In Simulation 5a some of the 
interactions remain the same as in the wild type whereas in Simulation 5b most of the analogous 
interaction observed in the binding site of the wild type are disrupted. 
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Figure 3.35: Representation of the protein- protein interactions in simulation (a and c) 6a (CPX-
Hel(L444P)) and  (b and d) 6b (CPX-Ext(L444P)) . Snapshot taken at 1000 ns of the simulation 
time. (a) General view of the complex GCase (white) and Sap-C (green), loops at the entrance of 
the binding site have been labelled and highlighted in cyan (6a) and purple (6b). (c and d) Detailed 
view of the protein binding site in simulation (c) 6a (CPX-Hel(L444P)) and (d) 6b (CPX-
Ext(L444P)). GCase has been depicted in white and Sap-C in green. Interacting residues of GCase 
have been coloured in cyan in simulation 6a and purple in simulation 6b. In simulation 6a and 6b 
many interactions occurring in the wild type are disrupted. This effect is pronounced in simulation 
6b where all the interactions with Loop-1 have been lost.  
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Figure 3.36: Some of the protein- protein interactions measured along the time in simulation 5a. 
 
Figure 3.37: Some of the Protein- protein interactions measured along the time in simulation 5b. 
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Figure 3.38: Some of the protein- protein interactions measured along the time in simulation 6a. 
 
Figure 3.39: Some of the protein- protein interactions measured along the time in simulation 6b. 
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Sap-C  5a-CPX-Hel 
N370S 
6a-CPX-Hel 
L444P 
5b-CPX-Ext 
N370S 
6b-CPX-Ext 
L444P 
E24 - S465 -  
K25 D445 
L444(bb) 
D445 
P444(bb) 
(until 650 ns) 
- - 
E26 - - K321 (from 
650 ns) 
- 
D29 - - K321 - 
D32 N362 (until 
300 ns) 
N362 (until 
600 ns) 
L317 (bb) - 
K33 D315 (from 
350 ns) 
D315 (until 
250 ns) 
- - 
S36 - - - - 
S43 - - - Q350 
E44 R353 Q350 - - 
Q47 - R353 (from 
400 ns) 
 
- Q350 
N353 
D51 Y487 
R44 
S12 (from 350 
ns) 
R44 (from 
300 ns) 
S12 (from 
350 ns) 
S465 (from 
500 ns) 
Y487 (from 
500 ns) 
R353 
W357 (bb) 
S55 Y487 - - D358 
Q362 (after 
750 ns) 
R44 (after 
750 ns) 
 
S56 - - K466 (from 
500 ns) 
- 
S59 S464 
S465 
- - - 
L62(bb) - - - - 
E63 K441 - - K466 
 
Table 3.6: Summary of protein-protein interaction in four simulations 5a, 5b, 6a and 6b. The 
abbreviation bb stands for ‘backbone’. 
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3.3.2.2.6. A comparison of wild-type N370 and L444 with mutants N370S and L444P 
N370 (simulation 3a, complex in active conformation) 
At the start of the simulation, N370 interacts with the side chains of residues T369 and 
S366. After 25 ns of simulations, the side chain of N370 located in helix-7 of Domain III 
flips towards b-strand 7 forming stable hydrogen bonds with the backbone atoms of 
residues W378 and G377, which are maintained throughout the course of the simulation.  
 
Figure 3.40: (a) Distance between residue N370 and residues S366, T369, W378 and G377, 
in simulation 3a (CPX-Hel). (b) Snapshot of the interactions between N370 and W378 (bb) 
and G377 (bb) in simulation 3a (CPX-Hel) at 1000 ns. 
 
L444 (simulation 3a, complex in active conformation) 
Backbone of residue L444 forms stable hydrogen bonds with the side chain of the residue 
K25 of Sap-C and N442, as well as with the backbone of residue N442. The side chain of 
the residue L444 lies in a hydrophobic pocket formed between the two b-sheets of Domain 
II. Residues A446, V460, V468, L470, I60, L65 also form a part of this pocket. 
 
N370 
W378 
G377 
a b 
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Figure 3.41: (a) Distance between residue L444 (bb) and residues K25 of Sap-C, N442 and N442 
(bb), in simulation 3a (CPX-Hel). (b) Snapshot of the interaction between residues L444 (bb) and 
K25 of Sap-C and N442 in simulation 3a (CPX-Hel) at 1000 ns. (c) Side chain of residue L444 lies 
in a hydrophobic pocket between the two Beta sheets of Domain II. 
 
N370 (simulation 3b, complex in inactive conformation) 
In the inactive conformation, N370 interacts with residue S366 and T369 in the same helix 
and forms very stable hydrogen bonds (Fig 3.42). N370 also interacts with the side chain 
of residue W312 in Loop-1. It should be worth mentioning here that difference in the 
conformation of Loop-1 is one of the markers that differentiate the active and inactive 
states of GCase. Thus an interaction between the side chain of N370 and residues in Loop-
1 is a direct link that plays a role in activation.  
 
Figure 3.42: (a) Distance between residue N370 and W312, S366 and T369 in simulation 3b (CPX-
Ext). (b) Snapshot of the interaction between N370 and W312, S366 and T369 in simulation 3b 
(CPX-Ext) at 1000 ns. 
W312 
S366 
T369 
N370 
a b 
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L444 (simulation 3b, complex in inactive conformation) 
Backbone of residue L444 forms stable hydrogen bonds with the side chain of the residue 
K25 of Sap-C and with the backbone of residue N442 and K441. The side chain of residue 
L444 lies in a hydrophobic pocket formed between two b sheets of Domain II. Residues 
A446, V460, V468, L470, I60, L65 also contribute in part to this pocket. 
 
 
Figure 3.43: (a) Distance between residue L444 (bb) and the side chain of K25 of Sap-C, K441 
(bb) and N442 (bb), in simulation 3b (CPX-Ext). (b) Snapshot of the interaction between residues 
L444 (bb) and K25 of Sap-C, K441 (bb) and N442 (bb) in simulation 3b (CPX-Ext) at 1000 ns. (c) 
Side chain of residue L444 lies in a hydrophobic pocket between two b sheets of Domain II. 
 
Mutant S370 (simulation 5a, N370S complex in active conformation) 
The mutant S370 forms a stable hydrogen bond with the side chain of residue S366 in the 
same helix. It also interacts with the backbone of residue V375 in b strand 7 up to 550 ns. 
Towards the end of the simulation, the mutated residue S370 interacts with residue W312 
in Loop-1. 
 
 
 
L444 
K25 
N442 
K441 L444 
a b c 
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Figure 3.44: (a) Distance between residue S370 and residues W312, S366 and V375 (bb) in 
simulation 5a (CPX-Hel(N370S)). (b) Snapshot of the interaction between N370 and W312 and 
S366 in simulation 5a (CPX-Hel(N370S)) at 1000 ns. 
 
L444 (simulation 5a, N370S complex in active conformation) 
Backbone of the L444, forms stable hydrogen bonds with the sidechain of the residue K25 
of Sap-C and with the sidechain of residue D443 and the backbone of residue N442. The 
sidechain of residue L444 is positioned in a hydrophobic pocket formed between the two 𝛽 − 𝑠heets of Domain II. Residues A446, V460, V468, L470, I60, L65 are part of this 
pocket. 
 
Figure 3.45: (a) Distance between residue L444 (bb) and residues K25 of Sap-C, K441 (bb), N442 
(bb) and D443, in simulation 5a (CPX-Hel(N370S)). (b) Snapshot of the interaction between 
residues L444 (bb) and K25 of Sap-C K441 (bb) and N442(bb) in simulation 5a (CPX-
Hel(N370S))at 1000 ns. (c) Sidechain of residue L444 lies in a hydrophobic pocket between the 
two b sheets of Domain II. 
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Mutant S370 (simulation 5b, N370S complex in inactive conformation) 
As observed in the active conformation, the mutant S370 forms a stable hydrogen bond 
with the side chain of the residue S366 in the same helix, but also with the residue T369 
during the entire simulation. S370 also interacts with W378 in b strand 7. From ~ 500 ns 
the mutated residue interacts with R285 in helix 5, and forms a stable interaction until the 
end of the simulation.  
- 
Figure 3.46: (a) Distance between residue S370 and residues W378, S366, T369 and R285 in 
simulation 5b (CPX-Ext(N370S)). (b) Snapshot of the interaction between N370 and W378, S366, 
T369 and R285 in simulation 5b (CPX-Ext(N370S)) at 1000 ns. 
 
L444 (simulation 5b, N370S complex in inactive conformation) 
Backbone of residue L444 does not form a hydrogen bond with residue K25 of Sap-C. The 
interaction is disrupted along with the other interactions that K25 of Sap-C makes with 
surrounding residues. The backbone atoms of L444 form a stable bond with the sidechain 
of residue D443 and the backbone of residue N442. As observed in the wild type, the 
sidechain of residue L444 is positioned in a hydrophobic pocket formed between the two 𝛽-sheets of Domain II. Residues A446, V460, V468, L470, I60, L65 form also part of this 
pocket. 
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Figure 3.47: (a) Distance between residue L444 (bb) and residues K25 of Sap-C, and D445 and 
K25 of Sap-C in simulation 5b (CPX-Ext(N370S)). (b) Snapshot of the interaction between residues 
L444 (bb) and K25 of Sap-C, K441 (bb) and N442 (bb) in simulation 5b (CPX-Ext(N370S)) at 1000 
ns. (c) Sidechain of residue L444 lies in a hydrophobic pocket between the two b sheets of Domain 
II. 
 
N370 (simulation 6a, L444P complex in active conformation) 
N370 interacts with the backbone of the residues G377 and V375 in the b strand 7 via 
hydrogen bonds. At 500 ns the side chain of residue N370 flips and establishes hydrogen 
bonds with residues W312, S366 and W378. However, this is transitional and only lasts 
for about 100 ns.  
 
Figure 3.48: (a) Distance between residue N370 and residues W378, S366, W312, V375 and G377 
along simulation 6a (CPX-Hel(L444P)). (b) Snapshot of the interaction between N370 and G377 
in simulation 6a (CPX-Hel(L444P)) at 1000 ns. 
CHAPTER 3: MOLECULAR DYNAMICS 
	
 132 
Mutant P444 (simulation 6a, L444P complex in inactive conformation) 
The interaction between P444 and residue K25 of Sap-C, which is present in rest of the 
simulations, is disrupted in simulation 6a from ~ 600 ns of the simulation. The backbone 
of P444 forms hydrogen bond interactions with residue N442 and with residue D445. P444 
lies inside a hydrophobic cluster in the middle of the two beta sheets that forms Domain II. 
These hydrophobic interactions are maintained in the L444P mutant.  
 
 
Figure 3.49: (a) Distance between residue P444 (bb) and residues K25 of Sap-C, D443 and N442 
in simulation 6a (CPX-Hel(L444P)). (b) Snapshot of the interaction between residues P444 (bb) 
and K25 of Sap-C, D443 and N442 (bb)  in simulation 6a (CPX-Hel(L444P)) at 1000 ns. (c) 
Sidechain of residue L444 lies in a hydrophobic pocket between the two b sheets of Domain II. 
 
N370 (simulation 6b, L444P complex in inactive conformation) 
N370 interacts with residue S366 and T369 in the same helix along the simulation time in 
a stable hydrogen bond. N370 forms a hydrogen bond with residue R285 until 400 ns after 
which it gets broken. From 400 ns onwards, two other interaction are formed, between 
residues W312 in Loop-1 and H374 in the loop connecting helix 7 and b strand 7. 
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Figure 3.50: (a) Distance between residue N370 and residues R285, W312, S366, T369 and H374 
along simulation 6b (CPX-Ext(L444P)). (b) Snapshot of the interaction between N370 and W312, 
S366 and T369 in simulation 6b (CPX-Ext (L444P)) at 1000 ns. 
 
Mutant P444 (simulation 6b, L444P complex in inactive conformation) 
The interaction between P444 and K25 of Sap-C, which is present in rest of the simulations, 
is disrupted in simulation 6b. The backbone of P444 forms hydrogen bond interactions 
with residue N442 in the first half of the simulation, after which it begins to interact with 
residue K441 in a less stable interaction. 
 
Figure 3.51: (a) Distance between P444 (bb) and residues K25 of Sap-C and N442 (bb) in 
simulation 6b (CPX-Ext(L444P)).  (b) Snapshot of the interaction between residues P444 (bb) and 
N442 (bb) in simulation 6b (CPX-Ext(L444P)) at 750 ns, (interaction with residue K25 of Sap-C 
does not occur in this simulation). (c) Mutation to residue P444 disrupts the hydrophobic pocket 
between the two b sheets of Domain II. 
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3.4. Discussion  
Our motivation in the present research has been to understand the dynamics of GCase at 
atomistic level and the role of its different components, in order to give a plausible 
structural explanation of the implications of the different mutations found in Gaucher’s 
Disease. Molecular Dynamics allows us to follow the dynamic evolution of a biological 
system. Simulations of >500 ns can highlight the dynamics of a membrane protein. 
Simplified techniques such as Coarse-Grained help to accelerate the process. 
In spite of many in vitro experiments, there is no evidence of an interaction between GCase 
and Sap-C in solution, i.e. in absence of a lipid bilayer.123,124,125 However, the interaction 
of both is recovered when lipids are added. Negatively-charged lipids are abundant 
component of the intralysosomal membrane126 and are required for the activation of GCase 
by Sap-C.123,124,125 In 2007, Jean-René Alattia et al. studied activation by Sap-C and 
observed that GCase hydrolyses its substrate at the bilayer level with the help of SapC 
within a complex at the membrane surface.127 They proposed a “liftase” mode of action for 
Sap-C according to which GCase would not be able to penetrate the membrane, thus 
GluCer ought to be ‘‘lifted’’ for proper docking to the active site. Using a membrane-bound 
fluorogenic substrate analogue, they observed an increase in the GCase of 17-fold in 
presence of Sap-C. The group postulated that this SapC-induced enhancement in the 
enzymatic activity should also be related to a greater intrinsic activity of GCase within an 
activator complex, probably involving a conformational change in the hydrolase, as 
observed in the case of pancreatic lipase.128 
 Alattia et al. finding highlighted the importance of studying the activation process within 
a lipid membrane. Based on that hypothesis, we conducted four MD runs where we have 
simulated GCase alone, with its substrate, as an entire complex with its facilitator protein 
Sap-C and the facilitator protein alone, always in presence of a lipid membrane. Coarse- 
grained simulations gave us the opportunity to observe the lipid self-assembly process. 
Quality controls demonstrated the correct formation of the membrane. GCase and Sap-C 
anchored to the membrane as peripheral membrane protein in all the simulations, as it was 
CHAPTER 3: MOLECULAR DYNAMICS 
	
 135 
expected.  
The CG coordinates of all the simulations were transformed to atomistic. Additional 1000 
ns atomistic simulations were conducted in order to understand the conformational changes 
in more detail. The atomistic simulations included GCase in a membrane environment, 
GCase along with it substrate in active and inactive conformation, the entire complex with 
Sap-C and substrate in both conformations and the two most clinically important mutants 
in complex with Sap-C, using both conformations of the enzyme, active and inactive.  
The structural stability of the systems was assessed by measuring the RMSD values. The 
results of RMSD were expected and followed a trend. The values of RMSD were more 
stable when GCase was simulated along with Sap-C (Simulation 3a and 3b). The mutated 
proteins exhibited a similar trend when in complex with Sap-C and when GCase is 
simulated alone. These results mean that Sap-C was able to stabilise the enzyme during the 
simulation of the complex. The complexes of the two mutants, in both conformations were 
more unstable than their wild type counter part. When GCase is simulated in extended 
(inactive) conformation, it exhibits higher RMSD values than when it is simulated in active 
conformation, indicating a higher conformational flexibility.  
The RMSF values were analysed in the context of loop dynamics, interactions within the 
binding site and protein- protein interaction. The highest peaks of RMSF corresponded to 
surface loops whereas the core structure was stable. Some differences were observed in the 
loops present at the entrance of the binding site. Simulations of GCase alone (2a and 2b) 
displayed higher RMSF in Loop-1. Subsequent analysis showed that Loop-1 partially lost 
its helical form during Simulation 2a (GCase-Hel and GluCer), whereas it extended 
towards helix 7 in simulation 2b (GCase-Ext and GluCer). In simulation 3a (CPX-Hel), 
Loop-1 conserved its helicity during the entire simulation due to the restraint placed by 
interaction with residue K33 of Sap-C. Finally, in simulation 3b (CPX-Ext), Loop-1 does 
not change its extended conformation. Loop-2 displayed RMSF values above 2 Å in two 
simulations, 2a (GCase-Hel and GluCer) and 3b (CPX-Ext). In simulation 2a (GCase-Hel 
and GluCer), the loop goes from an active conformation to become embedded inside the 
lipid membrane, and 3b (CPX-Ext), where the loop gets tucked in a hydrophobic pocket 
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under Sap-C. Only during simulation 3b, Loop-3 displayed high RMSF. During this 
simulation the loop goes from a closed conformation, where the side chain of residue R395 
points towards the inside of the binding pocket, to an open conformation. In both 
simulations of the wild type active conformation (2a and 3a), the RMSF value of Loop-4 
peaks above 2 Å. Analysing the interactions occurring within the binding site, this loop 
was observed to interact with the substrate within the active site in the active conformation.  
In the simulations of mutants in extended conformation (5b and 6b), Loop-1 displays high 
RMSF values around residues near helix 6. Helix 6 loses its helical conformation during 
the simulation and extends towards helix 7 and the membrane. A similar behaviour of this 
loop is also observed in the mutant active conformation 6a (CPX-Hel(L444P)) and partial 
(only the lower part of the helix) unfolding in the wild type inactive conformation when 
run without Sap-C, in simulation 2b (GCase-Ext and GluCer). The deformation of the helix 
6 and part of the Loop-1 result in structural instabilities at the protein- protein interface, 
which partially detaches Sap-C from GCase.  
Analysis of the dynamics of the loops at the entrance of the binding site in GCase shed 
light on the influence of the facilitator protein Sap-C. We have focused our efforts in 
analysing Loop-1, 2 and 3, as these are the activation loops, whereas Loop 4 and 5 have a 
structural and role in molecular recognition. Simulations of active mutants, although they 
do not exist in nature have helped us to understand part of the activation/ inactivation 
process. 
Loop-1 (H311-P319) has been reported to adopt a helical conformation in the active state 
of the enzyme, as demonstrated in different crystallization experiments27. In the helical 
conformation, the side chain of residue D315 points towards the outside of the binding site. 
The helicity of Loop-1 is partly lost when GCase is simulated without Sap-C, in simulation 
2a (GCase-Hel and GluCer) (Figure 3.13). In simulation 3a (CPX-Hel), the helicity is 
maintained because of a stable interaction, that lasts the entire simulation, between the 
residues D315 of GCase and K33 of Sap-C. In simulation of the mutant N370S active 
conformation 5a, the helical conformation of the loop is completely lost at the beginning 
of the simulation. This recovers partly once a hydrogen bond interaction is formed between 
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D315 and K33. This is also observed in simulation 6a (CPX-Hel(L444P)). At the beginning 
of the simulation, Loop-1 loses it helical form. This is recovered after the formation of a 
hydrogen bond between D315 and K33 of Sap-C. Following this bond formation, the 
helicity is maintained due to additional interactions with H365 an S366 in helix 7. In 
simulation 2a, where active GCase is simulated without Sap-C, Loop-1 partially loses 
helical form and establishes interactions with some residues of Loop-2, namely W348 and 
K346. In simulation 3b (CPX-Ext), residue K33 of Sap-C interacts via hydrogen bonds 
with the backbone atoms of L314 and Y373 throughout the simulation. It is important to 
note that these two residues surround the residue D315. In this thesis, we propose a 
helication mechanism of Loop-1 based in the interaction of residue D315 of GCase and 
K33 of Sap-C. In our model of activation residue K33 of Sap-C would form an ion pair 
that would take D315 from interacting with residues of Loop-2 (extended conformation) 
to interact with residues in helix 7.  
 
Figure 3.52: Evolution of Loop-1 in simulation 6a (CPX-Hel(L444P)) at (a) 200, (b) 400 and (c) 
800 ns. GCase has been depicted in white with the interacting residues in pink and Sap-C has been 
coloured in green. At the beginning of the simulation, D315 is extended towards Loop-2 
(characteristic of Loop-1 of the inactive conformation). As the residue starts interacting with 
residue K33 of Sap-C, Loop-1 orients towards helix-7; a characteristic of the active conformation. 
An experimental study carried out by Joel L. Sussman’s group in 2005 detected significant 
structural changes in both Loop-2 and Loop-3 upon the binding of the irreversible inhibitor 
CBE (Conduritol-B-Epoxide).129 The said study suggests that both loops act as a lid of the 
active site, thus highlighting the importance of both in the activation of the enzyme. Both 
Loops presented a closed conformation upon CBE binding. In Loop-2 there were no 
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prominent structural changes in the structure of the loop, although in the inactive 
conformation the loop seemed closer towards the binding site. In Loop-3 the structural 
changes were greater with bulky residues R395 and F397 pointing towards the binding site. 
Analogous loops in the enzyme glycosyl transferase have also been reported to be 
important for its activation.130  
In this thesis, we have described above how Loop-2 adopts an open conformation in 
presence of Sap-C. In the wild type simulations 3a (CPX-Hel) and 3b (CPX-Ext), residue 
W348 is tucked in a hydrophobic pocket made by Sap-C at the interface of both proteins. 
In the mutants except in 5a (CPX-Hel(N370S)), W348 is not tucked inside this binding 
pocket. Among all the simulations of extended conformation only 3b (CPX-Ext) presented 
an open conformation of Loop-3. In the rest of the simulations of the extended 
conformation, namely 2b (GCase-Ext and GluCer), 5b (CPX-Ext(N370S)) and 6b (CPX-
Ext(L444P)), residue R395 in Loop-3 formed a hydrogen bond interaction with residue 
E340 that completely obstructed the binding pocket. In this thesis, we would like to propose 
an opening mechanism for both Loop-2 and Loop-3 based on these observations. The 
opening mechanism of Loop-2 would depend on Sap-C, and relies on the fact that residue 
W348 of Loop-2 gets trapped in a hydrophobic pocket upon the binding of the facilitator 
protein. Tethering of residue W348 by Sap-C would not only produce the opening of Loop-
2, but also disrupt some important interactions between Loop-2 and Loop-3. This would 
also prompt the opening of Loop-3. The change in conformation of Loop-3 coincides with 
the stabilization of the spatial position of W348. This has been illustrated in Figure 3.53. 
The structural differences found at the protein- protein interface and the stability of 
interactions in different simulations, reflect the dynamics of the protein- protein 
recognition. Proteins do not fit in a static manner as building blocks but via a flexible and 
evolving process. Nonetheless, the disruption of some of these interactions can alter the 
process and makes protein- protein interaction impossible.  
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Figure 3.53: Stabilization of the side chain of W348 inside the hydrophobic pocket formed by Sap-
C. This coincides with the opening of Loop-3 in simulation 3b. (a) Interactions of residues W348 
and R395 at 200 ns, (b) interactions of residues W348 and R395 at 500 n., GCase has been depicted 
in white with interacting residues in yellow and Sap-C in green. (c) Distance between pair of 
residues (R395-S345, R395-Y313, W348-Y487, W348-L38) in simulation 3b. 
Mutant L444P was reported to present a dramatic decrease in the activation by Sap-C, 
suggesting that the mutation can directly hamper the formation of the activator complex.131 
In this thesis, present a structural explanation for this reduction in the activation of the 
mutant. The mutation of L444 to Proline, a less bulky and more rigid residue, possibly 
prevents the interaction with residue K25 to occur. As a result, there are no interaction 
between Sap-C and GCase.  
Mutant N370S has been reported to have a poor association with Sap-C unless the 
membrane is highly enriched with anionic phospholipids (>50%),42 whereas in the wild 
type an extensive enzyme- Sap-C association occur when the anionic phospholipid 
threshold exceed 10%.132 We observed that mutant N370S appeared to destabilize GCase, 
where Loop-1 extends towards helix 7, hampering the association with Sap-C.    
On the other hand, some residues of Sap-C seemed to be key in making protein- protein 
interaction. For example D29 and D32 make stable interactions with the hydrogen bond 
donor residues in helix 7: N362, H365, T369 and Y373. K33 and K25 also seem to be 
decisive for the protein-protein interaction. K25 interacts with L444 and surrounding 
residues whereas K33 interacts with D315. Furthermore, serines and tyrosines at the edge 
of Domain II, facing helix 7 also form substantial interactions at the interface.  
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Molecular dynamics simulations allow us to study structural dynamics and the activation 
mechanism of GCase. However to thoroughly explore the conformational space of the 
protein further analysis is required.
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CHAPTER 4:  KINETIC STUDIES 
4.1. Introduction 
Proteins are not static, but dynamic entities that exist as collections of interconvertible 
conformations in thermal equilibrium.133 Thermodynamic fluctuations allow the protein to 
visit other conformations in a multidimensional free energy landscape (FES).134,135,136,137 
Conformational FES of proteins are rough surfaces with multiple hills and valleys of 
different depths and heights. Each valley represents a low-energy state and is populated by 
an ensemble of related conformations called substates. A substate is formed by a set of 
energetically and structurally similar conformations that are called microstates.133 
Substates are separated by energy barriers of different heights. If few substates are 
separated by low energy barriers they can be considered a new substate, if they are 
collectively separated from other distant substates by higher barriers. Thus, 
Conformational FES has a multilevel organization.138 When the protein transits form one 
substate to another there are some intermediate, unstable and scarcely populated 
conformations named metastable states. Metastable states are the equivalent to the 
transition state in a chemical reaction and would be impossible to isolate by physical 
techniques.138 
The conformational changes that a protein can undergo vary from the vibration of a bond 
or the movement of a small group of atoms to concerted movements in which the entire 
protein is involved.133 The former are fast motions and occur in the ps to ns timescale. Fast 
motions allow the protein to visit close conformations within its substate. The latter are 
slow motions that occur in the 𝜇𝑠	to ms timescale. Slow motions allow the protein to 
explore distant substates in the conformational FES.134,133,138 Slow motions underlie the 
designated function of proteins.139 Big efforts have been made to understand slow 
conformational motions to unravel some important events such as protein folding, enzyme 
activation or ligand binding.133,134 
Atomistic MD is still not sufficient to draw a complete picture of the FES of a protein.140 
Since slow motions occur in the 𝜇𝑠	to ms timescale, it is difficult to obtain a trajectory that 
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surpass a few 𝜇𝑠 in a reasonable real time. In addition, the conformational motions in a 
MD simulation are highly dependent on the initial structure, which can bias the 
conformational search of the protein.133 Simple visual inspection of the trajectory and 
traditional measures such as RMSD can mislead the interpretation of the conformational 
subspace.140 Thus, new techniques of sampling and analysis of the macromolecular 
transitions, that supplement the MD data with statistical significance, should be introduced.  
The starting point of those methods should be a dimension reduction that simplify the MD 
output.140,141  
Anharmonic Conformational Analysis (ANCA) performs higher order statistics of 
conformational motions associated with the data sampled during the MD simulations, to 
identify substates.142,143 ANCA relies on the demonstrated fact that slow motions 
accountable for the protein function show high levels of anharmonicity.144 By focusing on 
the anaharmonicity ANCA is able to identify those conformational fluctuations that allow 
proteins to explore distant substates. ANCA links identified substates and conformational 
transitions to biophysical relevant characteristics highlighting the importance of those in 
the designated protein function.143  
Discrete state kinetics models such as Markov State Models (MSMs) have been shown to 
be successful to reconstruct protein conformational FES and transition pathways among 
substates, including the identification of transient states or metastable states.140,145 MSMs 
are able to extract information from a set of simulations of different starting points and 
reconstruct protein slow motions, even though those simulations are much shorter than the 
process to study.146  The resulting model is a network of discrete states (markovian) 
separated by probabilities of transitions. Also called transition network, MSMs produce 
efficient, easily readable models to study the conformational transition of proteins.145,147 
In this thesis, we have combined ANCA and MSMs to analyse the MD data from the wild 
type simulations in order to extract kinetic relevant information from the activation process 
of the enzyme GCase. Both techniques will be explained into greater depth in following 
sections.  
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4.1.1. Anharmonic Conformational Analysis (ANCA) 
Anharmonicity is demonstrated to be an essential characteristic of time-dependent 
conformational fluctuation of proteins.144,148,149 Anharmonic events are long (𝜇𝑠 to ms 
timescale) and rare events accountable for the designated function of biomolecules. ANCA 
uses fourth order statistics to explore anharmonicity of such events and thus characterise 
positional fluctuations responsible for conformational transition of proteins.143,134  Internal 
motions are then summarised using a small number of dominant anharmonic modes. 
Conformational space is partitioned in a series of substates and conformational transition 
in a multilevel motion hierarchy.138 
4.1.1.1. Kurtosis 
Kurtosis is a fourth order statistic measure of the anharmonicity in atomic fluctuation. For 
a real random variable, Kurtosis (𝜅) is defined as:133 
𝜅	 𝑞 = [{(r·)¸}º¸                 (4.1) 
where q denotes a real random variable, 𝜇 and 𝜎 represent respectively the mean and 
standard deviation of q and E{q} the expected value of the variable q. For unimodal 
distributions, the kurtosis is a measure of the peak or the proportion of the weights in the 
tails. For a Gaussian distribution with zero mean the value of 𝜅 is equal to 3. A super-
Gaussian, with heavier tails and more peaked would be greater than 3. Values of 𝜅 lower 
than 3 would define a sub-Gaussian distribution, a less peaked distribution. Either the 
Cartesian coordinates or dihedral angle selections can be used to calculate the 𝜅 in 
ANCA.133  
To study the evolution of the 𝜅 throughout the simulation time and spot possible events, a 
sliding window analysis should be carried out. For that, we can use an exponential window 
located at time t, a weight:150 
𝑊p= 𝛼𝑒r(vrp) ½    (4.2) 
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where k is a frame from the past (k < t) and 𝜏 is the time constant for exponential weight 
decay. The weights are natural solution for smoothing any considerable fluctuations 
observed in time evolving properties (like 𝜅) along the simulation time.150   
Kurtosis of the positional deviations can be projected onto a system built for each C𝛼. 
Thus, various researches have demonstrated that non-Gaussian distributions (either sub- or 
super- Gaussian) are associated with functionally relevant regions of proteins.142  
When the distributions of atom deviations are Gaussian-like, the ANCA basis vectors 
which maximize variance, align well with the intrinsic orientation of the data.133 However, 
when the atomic distributions combine sub- and super- Gaussian distributions, the intrinsic 
orientations of the data could be non-orthogonal, being necessary higher-order 
correlations.133,150 To overcome those problems, namely higher-order correlations and non- 
orthogonality, ANCA introduces four modules for the characterization of anharmonic 
modes of motion in the conformational landscape. 
4.1.1.2. Solving Spatial and Temporal correlations. 
ANCA introduces four core modules for the analysis of MD simulations. These modules 
take atom coordinates for each frame as input: 3N x t, where 3N are the atomic coordinates 
in the three Cartesian coordinates (x, y and z) and t denotes the different conformations. 
SD2 module performs Principal Component Analysis (diagonalization of the covariance 
matrix) so as to eliminate dominant second order spatial correlations.144 Apart from the 
atom coordinates for the different conformations, SD2 requires, the subspace 
dimensionality (m) as input. m can be selected by examining the cumulative variance plots 
that this module yields. Thus, SD2 carries out PCA, returning the eigenvalues (size m × 1), 
eigenvectors B (3N or D × m) and a projection matrix Y = BT X (m × t).144,133  
SD4 module resolves the intrinsic non-orthogonal dependencies in positional fluctuations. 
The projection matrix, Y, from SD2 is used to build a fourth order spatially correlated 
cumulant tensor. Thus, SD4 diagonalizes this tensor and produces an anharmonic mode 
matrix W (3N or D × m). ANCA modes are thus ordered based on the kurtosis of the 
CHAPTER 4: KINETIC STUDIES 
 
 146 
projected coordinates; nevertheless, this ordering may not always correspond to a relevant 
reaction coordinate. To solve this, the user can define physical observables, more 
functionally and biologically relevant, e.g. the distant between two atoms or internal energy 
of the conformations.  
TD2 module performs TICA (Time-lagged Independent Component Analysis) so as to 
remove dominant second order temporal correlations by computing a time-delayed 
covariance matrix. This module requires the atomic coordinates, and the subspace 
dimensionality of SD2 as input, but also another parameter the lag time (τ) over which the 
temporal correlations are to be resolved. This module returns Z, a matrix obtained by 
projecting the simulation data on the dominant eigenvectors and the eigenvalues.151,152  
TD4 module is the temporal analogue of the spatial SD4 module, it builds a time-delayed 
fourth-order kurtosis tensor, which is then diagonalized to obtain anharmonic modes of 
fluctuations once the second order spatial and temporal correlations are resolved.153 This 
module takes the matrix Z (from the TD2) as input, a user specified subspace value m 
denoting the number of desired anharmonic modes of motion, the lag time τ and the matrix 
V. The module returns the separating matrix W.  
The outputs from the module TD4 can be used to build a MSM that summarise the 
transition pathway between substates. 
	
4.1.2. Markov State Models (MSMs)		
The essence of Markov state models (MSMs) is to construct a model with a series of 
discrete states and to parameterize the model with the inter-conversion rates between those 
states.140 It is difficult to extract statistically relevant kinetic information by sheer 
visualization of MD trajectories. MSMs contribute to analyse a data set in a kinetically 
relevant manner.140,147 By partitioning the conformational space into discrete states, MSMs 
create coarse models constituted of many states that results in building of a high-resolution 
model of intrinsic kinetics. In order to create a MSM one needs to gather the kinetically 
relevant structure states and transition rates between those structures. 145 
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The first step in the creation of a MSM is a dimension reduction of the multidimensional 
conformational space. The dimension reduction is carried out through linear transformation 
methods such as Principal Component Analysis (PCA) or Time-lagged independent 
component analysis (TICA).144,151 Trajectories are filtered through the independent and/or 
principal components.151  Then, for the information to be gathered in a kinetic relevant 
manner, geometrical clustering methods such as k-means or k-centers are used.154 This 
clustering would result in generation of many microstates structurally similar, which 
suggests a high level of kinetic similarity. To identify the kinetic relation between the 
microstates, it is necessary to construct a transition matrix, detailing the transition rates 
between microstates at a fixed time (lag time).140,145  
To generate a transition matrix, the conformation of each frame of the trajectory is assigned 
to a microstate. Each structure in the trajectory is compared to the microstates. The closest 
microstate is identified and that structure is assigned to a relevant microstate. This means 
that the trajectories, which are frames over time, are converted to microstates.145 The next 
step is to identify the transition rates between each pair of microstates i and j at a specific 
lag time. For instance, if a trajectory is at microstate i at time t then we want to know how 
many times the simulation entered the state j at time t+x. This is called the count matrix 
Cij(). From that point, the probability of moving from i to j can be calculated in time which 
is known as Pij().155,156 The probability of inter-conversion between two states is calculated 
within the mathematical framework of the Transition Path Theory (TPT).157  The committor 
probability is essential to compute the transition pathway. The committor gives the 
probability to go from one intermediate state to the next one and not to the former.140 Thus, 
TPT allows the conversion flux to be computed and provides the probability of any 
conversion way. On the other hand, sampling is an important element to construct a 
converged MSM.145,158 Each microstate is not connected to the other, so to consider the 
number of transitions and amount of simulation per transition it is necessary to perform an 
efficient sampling.145,146 
After the sampling of the microstate transition matrix, the MSM can be constructed.140 
Defining states in a ‘‘kinetically relevant” way requires that structures within a state can 
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interconvert on timescales faster than the lag time. The number of microstates can be 
reduced by using longer lag times. So, increasing the lag time means that states can get 
larger and more coarse grained. A coarser model is more easily understandable if any 
relevant intermediate state is lumped. Typically, the coarse graining of the states is done 
via some sort of spectral clustering of the microstate transition matrix. This is done by 
checking the eigenvalues and eigenvectors of the transition matrix to identify kinetically 
similar states. These allow one to define a coarse grained model at arbitrary resolution 
(high or low) depending on the goals for the model by lumping together kinetically related 
microstates.140,145,146  
In this chapter, we present a MSM in which the dimensional reduction has been carried out 
using ANCA, instead of PCA or TICA.145 The rest of the MSM has been constructed as 
conventional. 
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4.2. Methodology 
The four simulations of the wild type protein in complex with Sap-C (3a and 3b) and alone 
(2a and 2b) were used to construct a kinetic model. Only the C𝛼 coordinates of the residues 
belonging to the active pocket, were used in this model. The residues selected were: 120-
130, 176- 181, 225- 261, 275- 296, 305-321, 340-356, 379-383 and 390-406. The analysis 
started from 400 ns onwards, considering the part before  the equilibration time. Each 
original simulation consisted of 25000 frames (25 frames per ns) and was decreased to 
5000 (skipping 5 frames), in order to accelerate the calculations. Thus, 3000 frames of each 
trajectory were processed in this analysis.  
We used mainly two python libraries to carry out the analysis, namely PyAnca143 and 
PyEmma145. Both were run in a Jupyter notebook159. Some complementary python libraries 
were implemented, intrinsically or by us, specifically: numpy112, scipy112, os160, 
matplotlib113, mdtraj111, mdanalysis161 and scikit-learn162. 
Trajectory and coordinates object were created using mdanalysis and mdtraj. A rigid body 
algorithm implemented in PyAnca: IterativeMeansAlign was used to align each step with 
the former one. Instant kurtosis, overall kurtosis and cumulative variance were obtained 
using scipy.stats (statistic module of scipy). RMSF and percentage anharmonicity for each 
residue were obtained within PyAnca.  
4.2.1. Spatio-temporal decorrelation 
Firstly, the module SD2 of PyAnca was used for removing spatial correlations. SD2 
computes the covariance matrix and performs PCA, which decorrelates the factors with lag 
spacing of zero.143 The dimension of the subspace was picked to be 60, based on the 
cumulative variance.  
The module TD2 of PyAnca computes time-delayed covariance matrix and performs PCA, 
thus removing second order temporal correlations.143 The dimensionality of the subspace 
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was specified to be 60, a decision based on the cumulative variance. The lag time selected 
was 1500 frames (300 ns), a time at which the different components stabilised.  
Finally, the module TD4 of PyAnca was used for removing fourth order temporal 
correlations. TD4 performs a joint diagonalization of time-delayed cumulant matrices. The 
dimensionality of the subspace was selected to be 25, in order to accelerate the calculations. 
The lag time specified was 1500 frames (300 ns), the time at which the different 
components stabilised.  
4.2.2. Markov State Model 
The results from TD2 and TD4 coordinates were used to construct a MSM. First, the new 
coordinates were clustered using K-means algorithm within Pyemma145. The number of 
clusters selected was 250, which resulted in the formation of 250 microstates. A microstate 
is a set of different conformation that are structurally and energetically related.  Then, the 
implied timescales were calculated for different lag times: 1, 2, 5, 10, 20, 50, 100, 200, 
500, 800, 1000, and 2000. This served us to decide the lag time to use to estimate our MSM. 
The relaxation time of the slowest process (800 steps) was selected to calculate the model.  
The Robust Perron Cluster Analysis Algorithm (PCCA) was used to coarse grain the data 
into a number of macrostates.153 PCCA assigns a probability of membership of each 
microstate (generated by clustering) to a macrostate. Thus, each macrostate is constructed 
by lumping together smaller sets of energetically and structurally similar conformations 
called microstates. In our model we select 5 macrostates, a decision based on the relative 
relaxation timescales.153,155 We finally obtained an MSM consisting of 5 macrostates as 
flux from a state A to a state B, with three intermediate states 0, 1 and 2.  
The 50 conformation samples from PCCA were analysed for each state. The majoritarian 
conformations within the sample have been shown for each state. The visualization tool we 
used for the trajectories was VMD. 114 
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4.3. Results 
4.3.1. Anharmonic Conformational Analysis 
In order to find the intrinsic dimensionality of the system, PCA was performed. PCA 
provides insights into how many modes are essential to estimate the number of 
conformational substates within the simulations. In our system, we identified that the first 
10 eigenvalues accumulated the 80 % of the covariance and that 60 eigenvalues accounted 
for the 95 % on the covariance (Fig. 4.1). This means that our system has 60 intrinsic 
dimensions, which the conformations will be projected on. The 60 dimensional space is 
also the space in which SD2 and TD2 calculation will be carried out. 
 
 
Figure 4.1: Cumulative variance of the system. The first 60 eigenvalues account for 95 % of the 
variance. This means that 60 is the intrinsic dimensionality of our system - the space that will be 
used for future calculations. 
Kurtosis was used to quantify anharmonicity (non-Gaussianity) from positional deviations. 
Non-Gaussian atomic deviations are associated with functional regions of the protein.134 
The overall kurtosis for our system was 5.41, so that it presents a super-Gaussian (𝜅> 3) 
distribution, and has a median of 4.5. Super-Gaussian distributions (GS) are more picked 
and heavier tailed than Gaussian distributions as can be seen in Figure 4.2 (b). 
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We have calculated what parts of the active site exhibit anharmonic motions and for how 
long. As we just selected the active site pocket for analysis. Most of the parts analysed 
exhibited high anharmonicity as illustrated in the figures 4.2(a) and 4.2(c). Loops-1 and -5 
exhibit high percentage of anharmonicity, along with the regions surrounding them. Loops-
2, -3 and -4 exhibit less percentage of anharmonicity. Regarding the kurtosis of individual 
residues, Loop-5 and surroundings exhibited high kurtosis, whereas the rest of the loops 
exhibited similar values. We have also included the values of RMSF per residue to compare 
with these results (Figure 4.2(d)). In the RMSF values fast motions have not been removed 
from the calculations, which is the reason why both measures RMSF and Kurtosis present 
different results. 
Spatial decorrelation was carried out using SD2 and selecting a subspace of 60 dimensions. 
The coordinates from SD2 (matrix Y) was used as input for TD2, which performed second 
order temporal decorrelation. The coordinates from SD2 were then used as input for TD2. 
A lag time of 1500 frames was selected to run TD2. Finally, the output from TD2 
(coordinates in matrix called Z) were used as input for TD4. TD4 carries out fourth order 
temporal decorrelation. TD4 was run using a lag time of 1500 and a space dimensionality 
of 25 dimensions.  
Figure 4.3. shows the trajectory through the first four components of TD4. As it is a time-
lag delayed calculation we called those components (TICA). It can be seen in the figure 
how TD4 has reduced the trajectories to a succession of discrete jumps as a result of 
dimensional reduction. The coordinates of TD4 were clustered using K-means algorithm. 
In order to improve the visualization, a histogram has been built of the first two TD4 
dimensions and the free energy computed. Figure 4.4(a) shows this histogram and 4.4(b) 
shows the clusters over the histogram. Each one of the clusters represents a microstate. 
Later in the analysis, the microstates will become a part of a larger macrostate, and the 
system will be reduced to a few states.  
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Figure 4.2. (a) Percentage of anharmonic time in our system. Loop-1 and Loop-5 exhibit higher 
percentage of anharmonicity. (b) Overall kurtosis of the system, illustrated as a super Gaussian 
distribution with a median value of 5.41. Positional desviations of the C𝛼 are anharmonic, non-
Gaussian. (c) Kurtosis values per residue: Loop-5 exhibits the greatest value of kurtosis, while the 
values of Loop-1 and Loop-3 were higher than the values of Loop-4 and Loop-5. (d) RMSF values 
per residue. Please note that the higher RMSD fluctuations do not involve high anharmonic 
percentage time or value of kurtosis per residues (fast motions have not been removed from the 
calculations). 
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Figure 4.3: Trajectory filtered through the first four TD4 components. Temporal and spatial 
decorrelation by modules SD2 and TD2 and TD4 facilitates the extraction of anharmonic modes 
of motion depriving the trajectory of Gaussian noise. The trajectory is thus reduced to a small set 
of discrete jumps, projected onto TD4 component values, that represent the independent, 
anharmonically fluctuating, protein motions. 
 
 
Figure 4.4: (a and b) Histogram of the first two TD4 components TICA 1 (x-axis) and TICA2 (y-
axis) and the computed free energy (b) Clusters as obtained from k-means are showed as black 
dots. 
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4.3.2. Markov State Model  
In this step, appropriate lag time selection as well as space discretization is performed. To 
identify the lag time, different lag times were scanned and relaxation timescale computed 
for each MSM. Initially the timescales are dependent of the lag times but after 800 steps 
(160 ns), it seems to stabilize (Figure 4.5). Thus a lag time of 800 steps was selected for 
the generation of a MSM using the coordinates from TD4.  
 
Figure 4.5: Relaxation timescales of different MSMs at different lag times. At small lag times the 
relaxation time is dependent on the lag time. From 800 steps onwards, the relaxation time of the 
slowest process is constant. The grey area indicates that the relaxation time is smaller than the lag 
time so the model cannot be predicted.  
Furthermore, spectral analysis was performed to obtain the calculated eigenvectors and 
identify the dominant motions in the TD4 analysis. The eigenvalues were represented by 
dots and the plots represent the overall impact of the 10 dominant eigenvectors in the 
overall motion (Figure 4.6(a)). This plot allows us to see the relaxation timescale of the 
dominant motions. Taking the ratios of the different relaxation timescales permits us to see 
the separation times between the different processes (Figure 4.6(b)). Relaxation timescales 
equates in faster motions, thus we can represent a model just by retaining those relaxation 
timescales that present more differences. In our model, we see how there is a gap between 
timescale separation of eigenvectors 0 and 1 and between 2 and 3 and 4, so that in our case 
it would be a good model if we choose 5 macrostates.  
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Figure 4.6: (a) Relaxation timescales of the dominant motions. (b) Relaxation timescale 
separations for the different process. Those with higher separation will be taken to represent the 
model.  
MSM’s as well as other kinetic models are approximations and therefore have non-zero 
systematic error. This error will depend on the type of model used, the lag time selected 
and the state space discretization. It is, therefore, mandatory to validate the kinetic model 
before using it for analysis.145 When the model, at a lag time 𝜏 , is capable of predicting 
estimates performed at a longer time scales 𝜅𝜏 within statistical error, the validation is 
considered successful. Chapman-Kolmogorov test compares the prediction and the 
estimation of probability of being in a set J at time 𝜅𝜏. The quality of our model was 
assessed using  Chapman-Kolmogorov test. Our model seemed to adjust to the estimation, 
Figure 4.7. 
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Figure 4.7. Quality of the model as assessed by Chapman-Kolmogorov test. The model is depicted as 
a black continuous line whereas the estimation is depicted as blue hashed line. It can be appreciated 
that our model correlated well to the estimation. 
The MSM microstates extracted by clustering ranges to hundreds and in some cases to 
thousands, do not provide a human understandable system. A coarse-grained model 
containing macrostates structures is generated by grouping the structures and adding up 
their equilibrium probabilities.156,163       
 Continuous molecular processes contain transition states that are not easily assignable to 
a cluster. To overcome the problem of transition states the concept of ‘fuzzy clustering’ 
was introduced. ‘Fuzzy clustering’ assigns every object to all the clusters with certain 
probability. The coarse grain process is done through PCCA analysis using fuzzy 
clustering.  PCCA determines the probability for each microstate to belong to a given 
macrostate. The probabilities are called memberships to a given macrostate. In the Figure 
4.8. we have plotted the Bayesian inverse. This is the probability of the structures that 
remain as a microstate when it is in a metastable state. 
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Figure 4.8: (a-e) Bayesian inverse plots for the distribution of the five longest living metastable 
states. The blue shadow represents the probability of membership to a metastable state, the darker 
the blue is the higher is the probability of belonging to a determinate metastable state. The probality 
is calculated for the first five components and projected in five plots in which TICA 1 (x-axis) and 
TICA2 (y-axis) are the axis. The predicted metastable states have been numbered in yellow. 
 
Coarse-graining further filtered irrelevant information. However, to construct a detailed 
markov state model, a transition pathway needs to be generated. In order to create a 
comprehensive transition pathway system, another PCCA clustering is employed targeting 
5 metastable states. 
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Figure 4.9: (a) Predicted metastable states projected on the first two eigenvectors. Each microstate 
has been coloured differently depending of the membership to a metastable state. (b) Demonstrates 
the two end states of the model within the density plot where the blue represents high density 
regions and the red shows the low density. Black dots are microstates belonging to the macrostate 
A whereas white dots are those belonging to the macrostate B. 
Moreover, the estimated time to go from A macrostate to B is 4.3 microseconds and 6.1 to 
come back.  
We finally plot our model with the transition probabilities (Figure 4.10). The probability 
fluxes of the pathway in the model are from the rightmost state to the leftmost state. In the 
model; the pathways moves from one stable state and then splits into two basic 
intermediary states, 0 and 2. From 0 it goes either to 2 or straight to B. From 2 it goes to 
an intermediate state 1 and from there to B or straight to B. 20 samples of each macrostate 
were taken and the 10 more similar were chosen to represent the macrostate. 
Figure 4.10 shows our final MSM. The model is composed of five macrostates as explained 
above. We have taken 50 samples from the PCCA for sampling each state. The majoritarian 
conformation among those 50 sample has been chosen to represent the state.  
The state A is represented by a structure that has Loop-1 in extended conformation while 
Loop-2 and Loop-3 have a closed conformation. From state A the fluxes split in four to 
state 0 or state 2 with high probability or to State 1 and B with little probability.  
State 0 is represented by a partially active conformation of the enzyme. Loop-1 is helical 
although partially extended, Loop-2 is in closed conformation and Loop-3 is in open 
conformation. From this state the flux goes to state 2. 
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The set of representative structures of state 1 exhibit an extended conformation of Loop-1, 
extended towards the helix 7, and Loop-2 and -3 in closed conformation. From State 1 the 
flux goes to state B.   
The set of representative structures in state 2 are characterised by an extended conformation 
of Loop-1, and open conformation of Loops-2 and -3. From State 2 it goes either to State 
1 or B. 
Finally, State B is represented by an active conformation of GCase that has a helical 
conformation of Loop-1, and open conformation of Loops 2 and 3.  
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Figure 4.10: The Markov State Model is composed of 5 macrostates. The set of structures, 
representative of each state has been illustrated in white with loops-1, -2 and -3 coloured in yellow, 
blue and green respectively. Inactive, intermediates (active and inactive) and active conformations 
of the protein has been labelled. The numbers are the transition times expressed in seconds.  
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4.4. Discussion  
Atomistic MD is still not sufficient to draw a complete picture of the FES of a protein.141 
The traditional MD analysis that measure conformational drifts, such as RMSD or radius 
of gyration, cannot be used to infer dominant motions accountable for protein function.140 
In this Chapter, higher order statistics and Markov state models have been combined to 
construct a kinetic model that allows us to dissect the conformational FES of the GCase, 
providing insights into the activation process. 
 The analysis has been carried out exclusively on the binding pocket of GCase to build this 
kinetic model. A total of 12000 conformations from 4 different simulations of the wild type 
of the enzyme GCase have been analysed. The quantification of anharmonicity using 
kurtosis as a measure, is able to recognise the functional parts of the proteins. Kurtosis and 
percentage of anharmonicity indicated Loop-1 as functionally relevant, whereas secondary 
role of the other Loops was also detected. However, it must be stressed here that only C𝛼 
atoms have been used in the analysis. This is in contrast to classical simulations where the 
open and closed state of Loop-2 and Loop-3 were influenced by sidechains positioning of 
residues W348 in Loop-2 and R395 in Loop-3, as explained previously. 
As the meaningful motions of the protein are concentrated in just a few dimensions it is 
unnecessary to cope with a multidimensional complexity.144,145,158 Fourth order statistics 
has been used to reduce the dimension of the data. TD4 was the final step in a series of 
transformations of our data. TD4 has been able to reduce our trajectory to a collection of 
discrete jumps. The components of TD4 can be further processed to isolate relevant 
discrete states liable for the functionality of the protein.  
The construction of a MSM is an efficient way to extract information from the eigenvectors 
and dispose it in a human readable format.140 The relaxation time of the slowest motion 
was around 800 ns. This suggests that transitions faster than 800 ns will be ignored in the 
results. We decided to represent the model in 5 substates after the relaxation timescale 
separation.  
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The MSM shows the transition among states. Our model describes a transition path in 
which the enzyme goes form an initial state A to a final state B via 3 different substates. 
During this transition we identified inactive, intermediate and active conformations of the 
protein. State A is represented by an inactive conformation of the protein, characterised by 
an extended conformation of Loop-1 and Loop-2 and -3 oriented towards the binding site. 
State B is represented by an active conformation of the enzyme characterised by a helical 
conformation of Loop-1, and open conformations of Loop 2 and 3. From State A to B the 
enzyme goes through a series of intermediate states. State 0 is represented by a partial 
active form (Loop-1 helical), where some features of the inactive conformation are present. 
Figure 4.10 illustrates how Loop-2 and -3 are oriented towards the binding site. From 0 the 
flux goes to State 2. State 2 is the lowest energy state, and hence extensively populated. 
The conformation representative of this state is again an intermediate state. Loop-1 is in 
extended conformation, although Loop-2 is dramatically open towards helix 7 and Loop-3 
is oriented toward the outside of the binding site. Finally, State 1 is a typical inactive 
conformation with an extended conformation of Loop-1. In this model the inactive enzyme 
passes through three intermediates states, to end up in an active conformation. It is 
important to note that the marked low energy state (State 2) does not correspond to any of 
the crystal structures. However, low energetic conformations are usually highly populated 
and can be easily isolated by physical techniques.135 It is important to stress here that the 
conformation in State 2 is similar to that observed towards the end of simulation 4b 
(inactive GCase and Sap-C), where Loop-2 was inserted in a hydrophobic pocket under 
Sap-C. The same conformation was proposed to influence Loop-3 to open towards the 
outside of the binding site and allow stable binding for the residue K33 of Sap-C to activate 
the Loop-1. It is possible that this very stable conformation has never been isolated because 
the structure of GCase along with Sap-C has never been studied physically.
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CHAPTER 5: CONCLUSIONS AND FUTURE WORK  
Understanding functional mechanism of the enzyme GCase would shed light on new ways 
to address the treatment for Gaucher Disease. In this thesis, I have presented a protein-
protein interaction model of the GCase with its facilitator protein, Sap-C, anchored into a 
lipid bilayer using Coarse- Grained molecular dynamics. The details of the interactions 
between different components and their evolution over time were observed by carrying out 
Atomistic Molecular Dynamics simulations. The difference in dynamics between wild type 
proteins and the clinically most important mutants (N370S and L444P) have also been 
addressed. A kinetic model accounting for the activation mechanisim of the enzyme has 
been presented.  
Protein- protein model  
The protein-protein interaction model proposed here is in agreement with experimental 
studies GCase-Sap-C binding. This model is also coherent with membrane anchoring 
experiments of both proteins separately and correlates well with the recent crystal structure 
of related GalC and Sap-A co-complex. The model was obtained using two different 
docking techniques. The model passed all the filters that we constructed to find our 
favourable conformation.  
Molecular Dynamics  
The anchoring of the GCase models in a DPPC membrane was performed in 5 different 
simulation environments, including, with and without facilitator protein Sap-C, and with 
and without substrate GluCer. In all cases GCase, anchored to the membrane and we were 
able to analyse the differences. The mode of binding obtained is coherent with 
experimental studies and theoretical predictions of interation of the proteins with the 
membrane.  
The analysis of Atomistic MD simulations provided the details of membrane anchoring, 
protein-protein and ligand binding. All systems showed overall structure stability. The 
main fluctuations were identified in external surface loops. The simulations including Sap-
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C helped us to locate important hydrogen bond networks at the protein-protein interface.  
In this thesis, I propose a mechanism of helication of Loop-1 through the interaction of 
residue D315 with residue K33 of Sap-C. This interaction was stable through the entire 
simulation in the active wild type simulation with the facilitator protein. The interaction 
was also observed in simulations of mutants containing Sap-C. The structural differences 
between these systems allowed us to study the details of this interaction. In simulation of 
the inactive wild type, residue K33 from Sap-C interacted with residues in the same Loop 
as D315, however this interaction was not observed in the mutants.  
The interaction between K33 (Sap-C) and Loop-1 are observed in the wild type (active and 
inactive) but not in the mutant. This is primarily because of a large number of hydrophobic 
interactions that stabilize the protein-protein interface. The stabilization of residue W348 
(Loop-2) in a hydrophobic pocket under Sap-C coincides with the disruption of interactions 
occurring between Loop-2 and Loop-3. The loss of these interactions allow Loop-3 to 
adopt an open conformation. Residue R395 of Loop-3 was found to make an ion-pair 
interactions with E340 in mutants and in GCase simulated without Sap-C. We observed 
that in mutants, W348 (Loop-2) is not stabilized in the hydrophobic pocket formed at the 
GCase-Sap-C interface.  
Mutants that were constructed from the active conformation, begin to show some features 
of inactivation, as the simulation progresses such as desestabilization of the residue W348 
in the hydrophobic pocket at the GCase-Sap-C interface and closure of Loop-3 in the case 
of L444P. Some of those inactive conformations features were also observed in simulation 
2a where the protein is simulated without Sap-C.  
Kinetic studies  
In this thesis, I present a kinetic model of activation of the enzyme GCase. The model was 
built using anharmonic conformational analysis (ANCA) and markov state models 
(MSMs). ANCA was able to detect the relevant role of Loop-1 in the activation process 
that traditional measures such as RMSF were not able to define. ANCA was used to 
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perform Spatio-Temporal decorrelation, and thus reduce the dimension of space and its 
discretization. ANCA reduced our trajectories to a set of discrete jumps, which can be 
easily analysed.  
An MSM model was built using the data reduced from ANCA. This model highlights an 
activation path of the enzyme GCase. The protein goes from an inactive state to an active 
state passing through three intermediate states. One of these intermediate states (2) was 
highly stable and extensively populated. The conformations that represent this State 2 were 
observed towards the end of simulation 4b. The intermediate state 2 can be correlated with 
the conformation that we proposed for the transition state structure, from active to inactive, 
observed in classical molecular dynamics.  
FUTURE WORK  
First, towards the end of the work that is presented here, the crystal structure of the enzyme 
GalC-Sap-A was published. Though belonging to the same family, GalC and GCase 
perform very different functions. The crystal structure shows Sap-A in an open 
conformation. Sap-C is only present in open conformation under detergent conditions. A 
dynamic model of GCase- open Sap-C has not been presented here. It should be simulated 
and included in future studies.  
Second, the atomistic simulations should be extended in order to improve the sampling of 
the FES of our system. While our simulations have equilibrated, they have not yet 
converged at the current timescale. Convergence will help us observe the end of the 
activation process proposed in this thesis.  
Third, a kinetic model with extended simulations could give us more information about the 
activation process including intermediates. Furthermore, a model that includes mutants can 
provide a more complete view of the FES of GCase.  
Finally, and although ambitious, structural implications of every mutation identified in 
Gauchers diseases should be looked into. A datebase of mutations and their structural 
implications will permit us to create a model able to link structural information with 
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phenotypic consequences.  
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